| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 8.49e-07 | 20 | 183 | 5 | GO:0061665 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 6.21e-06 | 50 | 183 | 6 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 8.76e-06 | 53 | 183 | 6 | GO:0016859 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.83e-05 | 36 | 183 | 5 | GO:0019789 | |
| GeneOntologyMolecularFunction | structural molecule activity | RPL21 COL7A1 ANK2 MAP1A PNN MAP2 SEPTIN4 MAP4 SYNM RPS3 MRPL37 PCLO COPB2 ADD1 AEBP1 ACAN AHNAK VCAN ERVK-5 COL14A1 LTBP1 TNXB | 2.35e-05 | 891 | 183 | 22 | GO:0005198 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | DIP2B FLNA FLNB XIRP1 CTTNBP2 ANK2 MAP1A MAP2 MAP4 SYNM RPS3 BCL7B IMPACT KIF12 CLSTN1 ADD1 SETD2 PTPRC ALMS1 ARHGEF10 TMOD1 CNGA3 NOS3 TBCC MX2 | 2.49e-05 | 1099 | 183 | 25 | GO:0008092 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | FLNA FLNB SERBP1 ICAM1 KIRREL2 TENM2 ADD1 PTPRJ PTPRZ1 AHNAK IGSF9 ARHGAP18 CDH3 TNXB CNGA3 NOS3 | 1.33e-04 | 599 | 183 | 16 | GO:0050839 |
| GeneOntologyMolecularFunction | small GTPase binding | RGPD4 DOCK2 FLNA RANBP2 RGPD8 RASGRF1 RGPD1 DENND1A RPTOR RGPD3 RINL | 1.91e-04 | 321 | 183 | 11 | GO:0031267 |
| GeneOntologyMolecularFunction | translation elongation factor binding | 2.49e-04 | 3 | 183 | 2 | GO:0061770 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 DOCK2 RANBP2 RGPD8 RASGRF1 ITSN1 SH2D3C RGPD1 DENND1A ARHGEF10 RGPD3 ARHGAP18 RINL RGPD5 | 2.51e-04 | 507 | 183 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 DOCK2 RANBP2 RGPD8 RASGRF1 ITSN1 SH2D3C RGPD1 DENND1A ARHGEF10 RGPD3 ARHGAP18 RINL RGPD5 | 2.51e-04 | 507 | 183 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase binding | 2.86e-04 | 35 | 183 | 4 | GO:0051019 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 3.56e-04 | 37 | 183 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | GTPase binding | RGPD4 DOCK2 FLNA RANBP2 RGPD8 RASGRF1 RGPD1 DENND1A RPTOR RGPD3 RINL | 5.06e-04 | 360 | 183 | 11 | GO:0051020 |
| GeneOntologyMolecularFunction | ubiquitin-like protein conjugating enzyme activity | 6.37e-04 | 43 | 183 | 4 | GO:0061650 | |
| GeneOntologyMolecularFunction | cytoskeletal regulatory protein binding | 8.20e-04 | 5 | 183 | 2 | GO:0005519 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 1.12e-03 | 279 | 183 | 9 | GO:0005096 | |
| GeneOntologyMolecularFunction | cadherin binding | 1.18e-03 | 339 | 183 | 10 | GO:0045296 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 6.91e-09 | 9 | 186 | 5 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 1.37e-08 | 10 | 186 | 5 | GO:1903301 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.73e-08 | 20 | 186 | 6 | GO:0006607 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 6.86e-08 | 13 | 186 | 5 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.06e-07 | 14 | 186 | 5 | GO:1903299 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 1.08e-06 | 38 | 186 | 6 | GO:0000413 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 3.54e-06 | 71 | 186 | 7 | GO:0006111 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 8.94e-06 | 54 | 186 | 6 | GO:0018208 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CHL1 FAT3 ICAM1 CLSTN1 WNK1 PLXNB2 TENM2 FAT2 ELFN1 IGSF9 IGSF21 CDH3 | 2.87e-05 | 313 | 186 | 12 | GO:0098742 |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | FLNA MAP1A MAP2 RPS3 ICAM1 ADD1 CRACD ALMS1 AEBP1 ARHGEF10 TPX2 TMOD1 ARHGAP18 TNXB | 4.61e-05 | 438 | 186 | 14 | GO:1902903 |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 4.68e-05 | 105 | 186 | 7 | GO:1901879 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 4.98e-05 | 144 | 186 | 8 | GO:0043244 | |
| GeneOntologyBiologicalProcess | mRNA transport | 5.23e-05 | 145 | 186 | 8 | GO:0051028 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | 6.68e-05 | 111 | 186 | 7 | GO:0006094 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 7.18e-05 | 195 | 186 | 9 | GO:0006606 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 8.36e-05 | 115 | 186 | 7 | GO:0019319 | |
| GeneOntologyBiologicalProcess | import into nucleus | 9.06e-05 | 201 | 186 | 9 | GO:0051170 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 1.15e-04 | 121 | 186 | 7 | GO:0046364 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 1.55e-04 | 89 | 186 | 6 | GO:1901880 | |
| GeneOntologyBiologicalProcess | nuclear transport | RGPD4 FLNA RANBP2 RGPD8 RGPD1 E2F3 WNK1 DMAP1 SETD2 RGPD3 MX2 RGPD5 | 1.73e-04 | 378 | 186 | 12 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | RGPD4 FLNA RANBP2 RGPD8 RGPD1 E2F3 WNK1 DMAP1 SETD2 RGPD3 MX2 RGPD5 | 1.73e-04 | 378 | 186 | 12 | GO:0006913 |
| GeneOntologyBiologicalProcess | RNA transport | 1.94e-04 | 175 | 186 | 8 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 1.94e-04 | 175 | 186 | 8 | GO:0050657 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 1.98e-04 | 132 | 186 | 7 | GO:0043255 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 2.17e-04 | 134 | 186 | 7 | GO:0010906 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 2.18e-04 | 178 | 186 | 8 | GO:0051236 | |
| GeneOntologyBiologicalProcess | ribosome hibernation | 2.41e-04 | 3 | 186 | 2 | GO:0141014 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | NES FLNA MAP1A MAP2 RPS3 ICAM1 CHMP4BP1 ADD1 CRACD CSF1R ALMS1 ARHGEF10 TPX2 TMOD1 ARHGAP18 | 2.54e-04 | 579 | 186 | 15 | GO:0051493 |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 2.93e-04 | 100 | 186 | 6 | GO:0043242 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 3.04e-04 | 187 | 186 | 8 | GO:0007156 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 3.37e-04 | 144 | 186 | 7 | GO:0051261 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | FLNA XIRP1 MAP1A MAP2 MAP4 RPS3 ICAM1 CASP5 ADD1 CRACD ALMS1 ADAMTS7 AEBP1 ARHGEF10 ACAN TPX2 TMOD1 COL14A1 ARHGAP18 TNXB | 4.19e-04 | 957 | 186 | 20 | GO:0097435 |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 4.46e-04 | 249 | 186 | 9 | GO:0015931 | |
| GeneOntologyBiologicalProcess | pyrimidine dimer repair by nucleotide-excision repair | 4.80e-04 | 4 | 186 | 2 | GO:0000720 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | CHL1 DIP2B CACNA1F NES FLNA FLNB NYAP2 MAP1A MAP2 FAT3 ICAM1 IMPACT NCAM1 PLXNB2 TENM2 ADD1 CSF1R PTPRJ PTPRZ1 IGSF9 ARHGAP18 CDH3 PLXNA2 | 4.85e-04 | 1194 | 186 | 23 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of cellular component size | LRRC8E DIP2B MAP2 PCLO ICAM1 E2F4 WNK1 ADD1 CRACD RPTOR TMOD1 ARHGAP18 | 5.09e-04 | 426 | 186 | 12 | GO:0032535 |
| GeneOntologyBiologicalProcess | heart development | HDAC9 FLNA NCOA6 XIRP1 ANK2 NCAM1 WNK1 FREM2 SETD2 PTPRJ NFATC1 ACAN VCAN COL14A1 LTBP1 NOS3 TP53BP2 | 5.18e-04 | 757 | 186 | 17 | GO:0007507 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | RGPD4 HDAC9 DIP2B RANBP2 RGPD8 ICAM1 SH2D3C RGPD1 TPGS2 WNK1 SIRT5 ADH5 SETD2 PTPRC CSF1R PTPRJ PTPRZ1 RPTOR RGPD3 NKTR | 5.37e-04 | 976 | 186 | 20 | GO:0018193 |
| GeneOntologyBiologicalProcess | cell volume homeostasis | 5.48e-04 | 42 | 186 | 4 | GO:0006884 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.90e-09 | 8 | 186 | 5 | GO:1990723 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CHL1 DIP2B CACNA1F ZC3H14 FLNA FLNB CTTNBP2 MAP1A RASGRF1 MAP2 SEPTIN4 RPS3 FAT3 PCLO ITSN1 CASP5 NCAM1 CLSTN1 SEZ6L2 DENND1A TENM2 ADD1 CSF1R PTPRZ1 ELFN1 ACAN RPTOR TPX2 IGSF9 LTBP1 WDFY3 ATP2B1 CNGA3 | 1.12e-08 | 1228 | 186 | 33 | GO:0036477 |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.28e-08 | 10 | 186 | 5 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 9.91e-08 | 14 | 186 | 5 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 4.12e-07 | 18 | 186 | 5 | GO:0044615 | |
| GeneOntologyCellularComponent | dendrite | CHL1 DIP2B ZC3H14 FLNA CTTNBP2 MAP1A RASGRF1 MAP2 SEPTIN4 RPS3 FAT3 PCLO ITSN1 CLSTN1 DENND1A TENM2 ADD1 PTPRZ1 ELFN1 RPTOR IGSF9 LTBP1 ATP2B1 CNGA3 | 6.94e-07 | 858 | 186 | 24 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CHL1 DIP2B ZC3H14 FLNA CTTNBP2 MAP1A RASGRF1 MAP2 SEPTIN4 RPS3 FAT3 PCLO ITSN1 CLSTN1 DENND1A TENM2 ADD1 PTPRZ1 ELFN1 RPTOR IGSF9 LTBP1 ATP2B1 CNGA3 | 7.23e-07 | 860 | 186 | 24 | GO:0097447 |
| GeneOntologyCellularComponent | nuclear inclusion body | 7.35e-07 | 20 | 186 | 5 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 9.58e-07 | 21 | 186 | 5 | GO:0106068 | |
| GeneOntologyCellularComponent | neuronal cell body | DIP2B CACNA1F FLNA FLNB MAP1A RASGRF1 MAP2 SEPTIN4 PCLO ITSN1 CASP5 NCAM1 SEZ6L2 DENND1A CSF1R PTPRZ1 ACAN RPTOR TPX2 LTBP1 WDFY3 ATP2B1 CNGA3 | 1.57e-06 | 835 | 186 | 23 | GO:0043025 |
| GeneOntologyCellularComponent | nuclear pore | 3.37e-06 | 101 | 186 | 8 | GO:0005643 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RGPD4 HDAC9 FLNA NCOA6 RANBP2 ERCC1 RGPD8 LEO1 PNN CDK12 RPS3 BCL7B INTS1 RGPD1 CHMP4BP1 E2F3 CHD8 E2F4 CHD4 XPC DMAP1 THAP11 POLR3E RGPD3 INTS15 TMOD1 POLR1B SNRNP200 MX2 RGPD5 | 4.63e-06 | 1377 | 186 | 30 | GO:0140513 |
| GeneOntologyCellularComponent | cell body | DIP2B CACNA1F FLNA FLNB MAP1A RASGRF1 MAP2 SEPTIN4 PCLO ITSN1 CASP5 NCAM1 SEZ6L2 DENND1A CSF1R PTPRZ1 ACAN RPTOR TPX2 LTBP1 WDFY3 ATP2B1 CNGA3 | 9.13e-06 | 929 | 186 | 23 | GO:0044297 |
| GeneOntologyCellularComponent | costamere | 3.92e-05 | 22 | 186 | 4 | GO:0043034 | |
| GeneOntologyCellularComponent | perineuronal net | 7.94e-05 | 10 | 186 | 3 | GO:0072534 | |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 1.09e-04 | 11 | 186 | 3 | GO:0098966 | |
| GeneOntologyCellularComponent | axon | DIP2B ZC3H14 FLNA MAP1A RASGRF1 MAP2 SEPTIN4 MAP4 PCLO ITSN1 SH2D3C AAK1 NCAM1 TENM2 PTPRZ1 ELFN1 TPX2 IGSF9 WDFY3 CNGA3 | 1.39e-04 | 891 | 186 | 20 | GO:0030424 |
| GeneOntologyCellularComponent | inclusion body | 1.53e-04 | 90 | 186 | 6 | GO:0016234 | |
| GeneOntologyCellularComponent | apical dendrite | 1.80e-04 | 32 | 186 | 4 | GO:0097440 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 1.86e-04 | 13 | 186 | 3 | GO:0099535 | |
| GeneOntologyCellularComponent | anchoring collagen complex | 2.35e-04 | 3 | 186 | 2 | GO:0030934 | |
| GeneOntologyCellularComponent | extracellular matrix | COL7A1 ZAN ICAM1 NCAM1 PLXNB2 FREM2 ADAMTS7 AEBP1 PTPRZ1 ELFN1 ACAN VCAN COL14A1 LTBP1 TNXB PLXNA2 | 2.67e-04 | 656 | 186 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | cell-cell junction | FLNA XIRP1 ANK2 PNN SYNM NCAM1 KIRREL2 TENM2 ADD1 FAT2 PTPRJ AHNAK PATJ IGSF21 CDH3 | 2.74e-04 | 591 | 186 | 15 | GO:0005911 |
| GeneOntologyCellularComponent | external encapsulating structure | COL7A1 ZAN ICAM1 NCAM1 PLXNB2 FREM2 ADAMTS7 AEBP1 PTPRZ1 ELFN1 ACAN VCAN COL14A1 LTBP1 TNXB PLXNA2 | 2.76e-04 | 658 | 186 | 16 | GO:0030312 |
| GeneOntologyCellularComponent | supramolecular fiber | NES FLNA FLNB ANK2 EFCAB6 MAP1A PNN MAP2 MAP4 SYNM KIF12 CHMP4BP1 TPGS2 HABP4 AHNAK TPX2 TMOD1 LTBP1 ARHGAP18 NBR1 TBCC MX2 AHNAK2 | 3.37e-04 | 1179 | 186 | 23 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | NES FLNA FLNB ANK2 EFCAB6 MAP1A PNN MAP2 MAP4 SYNM KIF12 CHMP4BP1 TPGS2 HABP4 AHNAK TPX2 TMOD1 LTBP1 ARHGAP18 NBR1 TBCC MX2 AHNAK2 | 3.71e-04 | 1187 | 186 | 23 | GO:0099081 |
| GeneOntologyCellularComponent | anchoring junction | FLNA FLNB XIRP1 ANK2 PNN SYNM RPS3 ICAM1 NCAM1 KIRREL2 TENM2 PRX ADD1 FAT2 PTPRC PTPRJ AHNAK PATJ IGSF21 CDH3 | 4.54e-04 | 976 | 186 | 20 | GO:0070161 |
| GeneOntologyCellularComponent | primary dendrite | 4.67e-04 | 4 | 186 | 2 | GO:0150001 | |
| GeneOntologyCellularComponent | nuclear envelope | RGPD4 RANBP2 PLAAT1 RGPD8 ITSN1 INTS1 RGPD1 CHMP4BP1 HABP4 RGPD3 FAM169A WDFY3 MX2 RGPD5 | 5.09e-04 | 560 | 186 | 14 | GO:0005635 |
| GeneOntologyCellularComponent | distal axon | FLNA MAP1A RASGRF1 MAP2 SEPTIN4 PCLO ITSN1 AAK1 NCAM1 TENM2 PTPRZ1 ELFN1 | 5.44e-04 | 435 | 186 | 12 | GO:0150034 |
| GeneOntologyCellularComponent | myofibril | 7.84e-04 | 273 | 186 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL7A1 ICAM1 NCAM1 PLXNB2 FREM2 AEBP1 PTPRZ1 ACAN VCAN COL14A1 LTBP1 TNXB PLXNA2 | 9.58e-04 | 530 | 186 | 13 | GO:0062023 |
| GeneOntologyCellularComponent | transferase complex | RGPD4 PRPSAP2 HDAC9 NCOA6 RANBP2 RGPD8 LEO1 VPS72 CDK12 NEK10 RGPD1 CHD8 DMAP1 PIGH UBE2N POLR3E RGPD3 POLR1B WDFY3 | 9.92e-04 | 963 | 186 | 19 | GO:1990234 |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.20e-03 | 290 | 186 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | asymmetric synapse | ANK2 MAP1A MAP2 MAP4 RPS3 PCLO CHD4 CLSTN1 ADD1 PTPRZ1 ELFN1 IGSF21 | 1.21e-03 | 477 | 186 | 12 | GO:0032279 |
| GeneOntologyCellularComponent | dendritic branch | 1.61e-03 | 7 | 186 | 2 | GO:0044307 | |
| GeneOntologyCellularComponent | sarcomere | 1.79e-03 | 249 | 186 | 8 | GO:0030017 | |
| GeneOntologyCellularComponent | axon initial segment | 2.14e-03 | 29 | 186 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | postsynaptic density | ANK2 MAP1A MAP2 MAP4 RPS3 PCLO CLSTN1 ADD1 PTPRZ1 ELFN1 IGSF21 | 2.44e-03 | 451 | 186 | 11 | GO:0014069 |
| GeneOntologyCellularComponent | ruffle | 2.52e-03 | 206 | 186 | 7 | GO:0001726 | |
| GeneOntologyCellularComponent | inhibitory synapse | 2.59e-03 | 31 | 186 | 3 | GO:0060077 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | ANK2 MAP1A MAP2 MAP4 RPS3 PCLO CHD4 CLSTN1 ADD1 PTPRZ1 ELFN1 IGSF21 | 2.60e-03 | 523 | 186 | 12 | GO:0098984 |
| GeneOntologyCellularComponent | axon hillock | 2.72e-03 | 9 | 186 | 2 | GO:0043203 | |
| GeneOntologyCellularComponent | ruffle membrane | 2.81e-03 | 108 | 186 | 5 | GO:0032587 | |
| GeneOntologyCellularComponent | perikaryon | 3.90e-03 | 223 | 186 | 7 | GO:0043204 | |
| GeneOntologyCellularComponent | nuclear membrane | 4.15e-03 | 349 | 186 | 9 | GO:0031965 | |
| GeneOntologyCellularComponent | postsynapse | RPL21 FLNA CTTNBP2 ANK2 MAP1A MAP2 MAP4 RPS3 PCLO ITSN1 NCAM1 CLSTN1 TENM2 ADD1 PTPRZ1 ELFN1 IGSF21 ATP2B1 | 4.36e-03 | 1018 | 186 | 18 | GO:0098794 |
| MousePheno | embryonic lethality before implantation, complete penetrance | RGPD4 RANBP2 RGPD8 PNN INTS1 RGPD1 NASP CHD4 DMAP1 RGPD3 EIF5B POLR1B ATP2B1 SNRNP200 | 5.69e-08 | 203 | 155 | 14 | MP:0011094 |
| MousePheno | embryonic lethality before implantation | RGPD4 RANBP2 RGPD8 PNN INTS1 RGPD1 NASP CHD4 DMAP1 RGPD3 INTS15 EIF5B POLR1B ATP2B1 SNRNP200 | 7.71e-08 | 242 | 155 | 15 | MP:0006204 |
| MousePheno | abnormal preimplantation embryo morphology | RGPD4 NCOA6 RANBP2 RGPD8 PPRC1 CDK12 RGPD1 CHD8 CHD4 PNPLA6 RPTOR RGPD3 POLR1B ATP2B1 TBCC | 5.83e-07 | 283 | 155 | 15 | MP:0014137 |
| MousePheno | elevated level of mitotic sister chromatid exchange | 6.22e-07 | 16 | 155 | 5 | MP:0003701 | |
| MousePheno | failure of blastocyst formation | 9.88e-07 | 31 | 155 | 6 | MP:0012129 | |
| MousePheno | increased lung carcinoma incidence | 2.32e-06 | 78 | 155 | 8 | MP:0008714 | |
| MousePheno | abnormal blastocyst formation | 4.07e-06 | 39 | 155 | 6 | MP:0012128 | |
| MousePheno | aneuploidy | 4.75e-06 | 61 | 155 | 7 | MP:0004024 | |
| MousePheno | abnormal chromosome number | 4.87e-06 | 86 | 155 | 8 | MP:0004023 | |
| MousePheno | abnormal olfactory bulb glomerular layer morphology | 6.72e-06 | 12 | 155 | 4 | MP:0009948 | |
| MousePheno | abnormal morula morphology | 8.56e-06 | 26 | 155 | 5 | MP:0012058 | |
| MousePheno | increased sarcoma incidence | 1.73e-05 | 102 | 155 | 8 | MP:0002032 | |
| MousePheno | decreased tumor latency | 1.79e-05 | 30 | 155 | 5 | MP:0010308 | |
| MousePheno | embryonic lethality prior to organogenesis | RGPD4 NES RANBP2 RGPD8 PNN PPRC1 CDK12 COPB2 INTS1 RGPD1 NASP CHD8 CHD4 PALB2 DMAP1 THAP11 PIGH UBE2N RPTOR RGPD3 INTS15 TPX2 EIF5B POLR1B ATP2B1 SNRNP200 SDHA TBCC TP53BP2 SON | 1.97e-05 | 1204 | 155 | 30 | MP:0013292 |
| MousePheno | increased lung tumor incidence | 2.46e-05 | 107 | 155 | 8 | MP:0008014 | |
| MousePheno | increased respiratory system tumor incidence | 2.46e-05 | 107 | 155 | 8 | MP:0010298 | |
| MousePheno | abnormal vascular development | FLNA FLNB NCOA6 PDZK1 ICAM1 WNK1 BIRC6 LEPR PALB2 SETD2 PNPLA6 PTPRJ ADAMTS7 VCAN TMOD1 LTBP1 NOS3 TP53BP2 | 3.18e-05 | 542 | 155 | 18 | MP:0000259 |
| MousePheno | abnormal tumor latency | 3.37e-05 | 34 | 155 | 5 | MP:0010307 | |
| MousePheno | abnormal eye electrophysiology | RGPD4 CACNA1F RANBP2 RGPD8 RGPD1 NCAM1 TENM2 LEPR ALMS1 RGPD3 CNGA3 | 4.71e-05 | 228 | 155 | 11 | MP:0005551 |
| MousePheno | embryonic lethality prior to tooth bud stage, complete penetrance | RGPD4 RANBP2 RGPD8 PNN PPRC1 CDK12 COPB2 INTS1 RGPD1 NASP CHD4 DMAP1 THAP11 UBE2N RPTOR RGPD3 EIF5B POLR1B ATP2B1 SNRNP200 TBCC SON | 4.82e-05 | 779 | 155 | 22 | MP:0014257 |
| MousePheno | enlarged brain ventricles | 5.98e-05 | 156 | 155 | 9 | MP:0011380 | |
| MousePheno | abnormal cardiovascular development | FLNA FLNB NCOA6 PNN PDZK1 ICAM1 CHD4 WNK1 BIRC6 LEPR PALB2 SETD2 PNPLA6 PTPRJ NFATC1 ADAMTS7 VCAN TMOD1 LTBP1 WDFY3 NOS3 TP53BP2 | 7.42e-05 | 802 | 155 | 22 | MP:0002925 |
| MousePheno | abnormal chromosome morphology | 7.93e-05 | 126 | 155 | 8 | MP:0003702 | |
| MousePheno | abnormal brain ventricle size | 8.80e-05 | 164 | 155 | 9 | MP:0013229 | |
| MousePheno | abnormal olfactory bulb layer morphology | 9.10e-05 | 22 | 155 | 4 | MP:0009946 | |
| MousePheno | enlarged epididymis | 1.14e-04 | 99 | 155 | 7 | MP:0004931 | |
| MousePheno | abnormal olfactory bulb morphology | 1.16e-04 | 133 | 155 | 8 | MP:0000819 | |
| MousePheno | abnormal forebrain morphology | CHL1 ZC3H14 NCOA6 ANK2 MAP2 SPEF2 ITSN1 PDZK1 COPB2 SH2D3C NCAM1 KIRREL2 PLXNB2 DENND1A TENM2 PRX PRDM2 THAP11 SETD2 CSF1R TPX2 WDFY3 CNGA3 NOS3 PLXNA2 TP53BP2 | 1.20e-04 | 1072 | 155 | 26 | MP:0000783 |
| MousePheno | increased hepatocellular carcinoma incidence | 1.23e-04 | 70 | 155 | 6 | MP:0003331 | |
| MousePheno | embryonic lethality prior to organogenesis, complete penetrance | RGPD4 RANBP2 RGPD8 PNN PPRC1 CDK12 INTS1 RGPD1 NASP CHD4 DMAP1 THAP11 UBE2N RPTOR RGPD3 EIF5B POLR1B ATP2B1 SNRNP200 TBCC SON | 1.23e-04 | 772 | 155 | 21 | MP:0014259 |
| MousePheno | abnormal eye physiology | RGPD4 CACNA1F RANBP2 ERCC1 RGPD8 ICAM1 RGPD1 NCAM1 XPC TENM2 LEPR ZSCAN10 ALMS1 VCAN RGPD3 SNRNP200 CNGA3 NOS3 | 1.33e-04 | 606 | 155 | 18 | MP:0005253 |
| MousePheno | abnormal susceptibility to weight gain | RGPD4 RANBP2 ANK2 RGPD8 RGPD1 IMPACT LEPR ALMS1 AEBP1 AHNAK RGPD3 NOS3 | 1.70e-04 | 309 | 155 | 12 | MP:0011117 |
| MousePheno | abnormal myocardial trabeculae morphology | 2.01e-04 | 144 | 155 | 8 | MP:0002189 | |
| MousePheno | abnormal cell nucleus morphology | 2.11e-04 | 184 | 155 | 9 | MP:0003111 | |
| MousePheno | abnormal telencephalon morphology | CHL1 ZC3H14 NCOA6 ANK2 MAP2 SPEF2 ITSN1 COPB2 SH2D3C NCAM1 KIRREL2 PLXNB2 TENM2 PRX THAP11 CSF1R WDFY3 CNGA3 NOS3 PLXNA2 TP53BP2 | 2.47e-04 | 812 | 155 | 21 | MP:0000787 |
| MousePheno | embryonic lethality prior to tooth bud stage | RGPD4 NES RANBP2 RGPD8 PNN PPRC1 CDK12 COPB2 INTS1 RGPD1 NASP CHD8 CHD4 PALB2 DMAP1 THAP11 PIGH UBE2N RPTOR RGPD3 INTS15 TPX2 EIF5B POLR1B ATP2B1 SNRNP200 SDHA TBCC TP53BP2 SON | 2.48e-04 | 1383 | 155 | 30 | MP:0013293 |
| MousePheno | abnormal olfactory lobe morphology | 2.54e-04 | 149 | 155 | 8 | MP:0009944 | |
| MousePheno | abnormal blastocyst hatching | 2.60e-04 | 113 | 155 | 7 | MP:0003693 | |
| MousePheno | impaired glucose tolerance | RGPD4 RANBP2 ANK2 RGPD8 RASGRF1 PPM1D RGPD1 AAK1 E2F3 CHD8 LEPR ALMS1 RGPD3 COL14A1 NBR1 | 2.89e-04 | 480 | 155 | 15 | MP:0005293 |
| MousePheno | increased malignant tumor incidence | RGPD4 RANBP2 RGPD8 RGPD1 XPC PRDM2 PTPRZ1 RGPD3 TPX2 TP53BP2 | 3.11e-04 | 237 | 155 | 10 | MP:0002018 |
| MousePheno | increased classified tumor incidence | RGPD4 TET2 RANBP2 RGPD8 MCM8 RGPD1 XPC PRDM2 PTPRZ1 RGPD3 INTS15 TPX2 TP53BP2 | 3.24e-04 | 381 | 155 | 13 | MP:0010273 |
| MousePheno | enlarged lateral ventricles | 3.36e-04 | 84 | 155 | 6 | MP:0008535 | |
| MousePheno | abnormal brain ventricle morphology | CHL1 ZC3H14 NCOA6 ANK2 SPEF2 PLXNB2 DENND1A THAP11 CSF1R WDFY3 TP53BP2 | 3.46e-04 | 286 | 155 | 11 | MP:0000822 |
| MousePheno | abnormal classified tumor incidence | RGPD4 TET2 RANBP2 RGPD8 MCM8 RGPD1 XPC PRDM2 PTPRZ1 RGPD3 INTS15 TPX2 TP53BP2 | 3.49e-04 | 384 | 155 | 13 | MP:0020188 |
| MousePheno | increased carcinoma incidence | 3.49e-04 | 197 | 155 | 9 | MP:0002038 | |
| MousePheno | abnormal rod electrophysiology | 3.57e-04 | 119 | 155 | 7 | MP:0004021 | |
| MousePheno | abnormal olfactory bulb periglomerular cell morphology | 3.64e-04 | 3 | 155 | 2 | MP:0009943 | |
| MousePheno | absent sperm annulus | 3.64e-04 | 3 | 155 | 2 | MP:0009835 | |
| MousePheno | decreased susceptibility to diet-induced obesity | 4.10e-04 | 160 | 155 | 8 | MP:0005659 | |
| MousePheno | abnormal brain ventricular system morphology | CHL1 ZC3H14 NCOA6 ANK2 SPEF2 PLXNB2 DENND1A ADD1 THAP11 FREM2 CSF1R WDFY3 TP53BP2 | 4.35e-04 | 393 | 155 | 13 | MP:0002200 |
| MousePheno | increased organ/body region tumor incidence | RGPD4 TET2 RANBP2 RGPD8 MCM8 RGPD1 XPC PRDM2 PTPRZ1 RGPD3 INTS15 TPX2 TP53BP2 | 4.56e-04 | 395 | 155 | 13 | MP:0010274 |
| MousePheno | abnormal lateral ventricle morphology | 4.84e-04 | 164 | 155 | 8 | MP:0000823 | |
| MousePheno | abnormal long bone morphology | PRPSAP2 FLNB COL7A1 SYNM AAK1 CHD4 LEPR FREM2 SETD2 ZSCAN10 PTPRC CSF1R ACAN LTBP1 NBR1 NOS3 SON CREB3L2 | 5.01e-04 | 676 | 155 | 18 | MP:0003723 |
| MousePheno | abnormal epididymis size | 5.24e-04 | 166 | 155 | 8 | MP:0004926 | |
| MousePheno | abnormal organ/body region tumor incidence | RGPD4 TET2 RANBP2 RGPD8 MCM8 RGPD1 XPC PRDM2 PTPRZ1 RGPD3 INTS15 TPX2 TP53BP2 | 5.26e-04 | 401 | 155 | 13 | MP:0013152 |
| MousePheno | decreased cell proliferation | NCOA6 ERCC1 MCM8 PPM1D E2F3 BIRC6 DENND1A LEPR PALB2 THAP11 PTPRC ADAMTS7 AEBP1 UBE2N RPTOR AHNAK TPX2 BARX1 NOS3 | 5.35e-04 | 739 | 155 | 19 | MP:0000352 |
| MousePheno | abnormal blastocyst morphology | 6.25e-04 | 259 | 155 | 10 | MP:0004957 | |
| MousePheno | increased incidence of induced tumors | 6.88e-04 | 173 | 155 | 8 | MP:0002021 | |
| MousePheno | thick retina ganglion layer | 7.22e-04 | 4 | 155 | 2 | MP:0008508 | |
| MousePheno | abnormal placental labyrinth vasculature morphology | 8.09e-04 | 99 | 155 | 6 | MP:0008803 | |
| MousePheno | increased tumor incidence | RGPD4 TET2 RANBP2 RGPD8 MCM8 RGPD1 XPC PRDM2 HABP4 PTPRJ PTPRZ1 RGPD3 INTS15 TPX2 TP53BP2 | 8.12e-04 | 530 | 155 | 15 | MP:0002020 |
| MousePheno | abnormal circulating free fatty acids level | 8.28e-04 | 222 | 155 | 9 | MP:0001553 | |
| MousePheno | abnormal epididymis morphology | 8.37e-04 | 269 | 155 | 10 | MP:0002631 | |
| Domain | Ran_BP1 | 7.17e-10 | 12 | 183 | 6 | PF00638 | |
| Domain | RANBD1 | 7.17e-10 | 12 | 183 | 6 | PS50196 | |
| Domain | RanBD | 1.32e-09 | 13 | 183 | 6 | SM00160 | |
| Domain | Ran_bind_dom | 1.32e-09 | 13 | 183 | 6 | IPR000156 | |
| Domain | Grip | 3.77e-08 | 11 | 183 | 5 | SM00755 | |
| Domain | GRIP | 3.77e-08 | 11 | 183 | 5 | PF01465 | |
| Domain | GRIP_dom | 6.40e-08 | 12 | 183 | 5 | IPR000237 | |
| Domain | GRIP | 6.40e-08 | 12 | 183 | 5 | PS50913 | |
| Domain | Rab_bind | 3.05e-07 | 7 | 183 | 4 | PF16704 | |
| Domain | GCC2_Rab_bind | 3.05e-07 | 7 | 183 | 4 | IPR032023 | |
| Domain | - | CHL1 FLNA FLNB COL7A1 ICAM1 NCAM1 KIRREL2 PLXNB2 IL18R1 LEPR PTPRC CSF1R PTPRJ NFATC1 PTPRZ1 VCAN CEACAM16 IGSF9 COL14A1 IGSF21 TNXB PLXNA2 | 5.98e-07 | 663 | 183 | 22 | 2.60.40.10 |
| Domain | Ig-like_fold | CHL1 FLNA FLNB COL7A1 ICAM1 NCAM1 KIRREL2 PLXNB2 IL18R1 LEPR PTPRC CSF1R PTPRJ NFATC1 PTPRZ1 VCAN CEACAM16 IGSF9 COL14A1 IGSF21 TNXB PLXNA2 | 1.69e-06 | 706 | 183 | 22 | IPR013783 |
| Domain | - | 1.79e-06 | 10 | 183 | 4 | 1.10.220.60 | |
| Domain | FN3 | CHL1 COL7A1 NCAM1 LEPR PTPRC PTPRJ PTPRZ1 IGSF9 COL14A1 TNXB | 1.47e-05 | 185 | 183 | 10 | SM00060 |
| Domain | FN3 | CHL1 COL7A1 NCAM1 LEPR PTPRC PTPRJ PTPRZ1 IGSF9 COL14A1 TNXB | 2.76e-05 | 199 | 183 | 10 | PS50853 |
| Domain | fn3 | 3.19e-05 | 162 | 183 | 9 | PF00041 | |
| Domain | FN3_dom | CHL1 COL7A1 NCAM1 LEPR PTPRC PTPRJ PTPRZ1 IGSF9 COL14A1 TNXB | 4.18e-05 | 209 | 183 | 10 | IPR003961 |
| Domain | IHABP4_N | 9.55e-05 | 2 | 183 | 2 | PF16174 | |
| Domain | IHABP4_N | 9.55e-05 | 2 | 183 | 2 | IPR032381 | |
| Domain | HABP4_PAI-RBP1 | 9.55e-05 | 2 | 183 | 2 | SM01233 | |
| Domain | UBQ-conjugating_enzyme/RWD | 1.68e-04 | 53 | 183 | 5 | IPR016135 | |
| Domain | TAU_MAP_2 | 2.85e-04 | 3 | 183 | 2 | PS51491 | |
| Domain | Tubulin-binding | 2.85e-04 | 3 | 183 | 2 | PF00418 | |
| Domain | MAP_tubulin-bd_rpt | 2.85e-04 | 3 | 183 | 2 | IPR001084 | |
| Domain | TAU_MAP_1 | 2.85e-04 | 3 | 183 | 2 | PS00229 | |
| Domain | MAP2/MAP4/Tau | 2.85e-04 | 3 | 183 | 2 | IPR027324 | |
| Domain | - | COPB2 PLXNB2 BIRC6 PALB2 ARHGEF10 WDR87 RPTOR MIOS WDFY3 PLXNA2 SON | 4.59e-04 | 333 | 183 | 11 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | COPB2 PLXNB2 BIRC6 PALB2 ARHGEF10 WDR87 RPTOR MIOS WDFY3 PLXNA2 SON | 4.82e-04 | 335 | 183 | 11 | IPR015943 |
| Domain | Ig_E-set | 5.59e-04 | 104 | 183 | 6 | IPR014756 | |
| Domain | TPR-contain_dom | 7.01e-04 | 150 | 183 | 7 | IPR013026 | |
| Domain | PDZ | 7.29e-04 | 151 | 183 | 7 | PS50106 | |
| Domain | PDZ | 7.58e-04 | 152 | 183 | 7 | IPR001478 | |
| Domain | NUT | 9.36e-04 | 5 | 183 | 2 | IPR024310 | |
| Domain | NUT_N | 9.36e-04 | 5 | 183 | 2 | IPR024309 | |
| Domain | NUT | 9.36e-04 | 5 | 183 | 2 | PF12881 | |
| Domain | PH_dom-like | RGPD4 RANBP2 RGPD8 RASGRF1 ITSN1 FRMPD1 RGPD1 MTMR4 ARHGEF10 RGPD3 WDFY3 RGPD5 | 1.04e-03 | 426 | 183 | 12 | IPR011993 |
| Domain | TPR_REGION | 1.22e-03 | 165 | 183 | 7 | PS50293 | |
| Domain | TPR | 1.22e-03 | 165 | 183 | 7 | PS50005 | |
| Domain | E2F_CC-MB | 1.40e-03 | 6 | 183 | 2 | IPR032198 | |
| Domain | BRK | 1.40e-03 | 6 | 183 | 2 | SM00592 | |
| Domain | BRK_domain | 1.40e-03 | 6 | 183 | 2 | IPR006576 | |
| Domain | E2F_CC-MB | 1.40e-03 | 6 | 183 | 2 | PF16421 | |
| Domain | BRK | 1.40e-03 | 6 | 183 | 2 | PF07533 | |
| Domain | - | 1.56e-03 | 51 | 183 | 4 | 3.10.110.10 | |
| Domain | Chromo_domain | 1.61e-03 | 24 | 183 | 3 | IPR023780 | |
| Domain | TPR | 1.71e-03 | 129 | 183 | 6 | SM00028 | |
| Domain | TPR_1 | 1.92e-03 | 90 | 183 | 5 | IPR001440 | |
| Domain | TPR_1 | 1.92e-03 | 90 | 183 | 5 | PF00515 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.39e-08 | 18 | 139 | 6 | MM1549 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 4.32e-05 | 40 | 139 | 5 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 4.89e-05 | 41 | 139 | 5 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 5.50e-05 | 42 | 139 | 5 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 6.18e-05 | 43 | 139 | 5 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 9.54e-05 | 47 | 139 | 5 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.17e-04 | 49 | 139 | 5 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.29e-04 | 50 | 139 | 5 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.41e-04 | 51 | 139 | 5 | MM15151 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.56e-04 | 82 | 139 | 6 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.78e-04 | 84 | 139 | 6 | MM14929 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 2.03e-04 | 55 | 139 | 5 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 2.61e-04 | 58 | 139 | 5 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 2.61e-04 | 58 | 139 | 5 | MM14736 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.93e-04 | 92 | 139 | 6 | MM14951 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 4.46e-04 | 65 | 139 | 5 | MM15147 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | DIP2B FLNA NCOA6 RANBP2 LEO1 PNN MAP4 CDK12 RPS3 ITSN1 AAK1 NASP CHD4 XPC PALB2 ADD1 PRDM2 ESF1 TRIM16 SETD2 PTPRC PNPLA6 RPTOR TPX2 EIF5B SNRNP200 SON | 1.96e-14 | 774 | 189 | 27 | 15302935 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RPL21 ZC3H14 FLNA RANBP2 SERBP1 ANK2 MAP1A PNN MAP4 CDK12 MRPL37 AAK1 NASP CHD4 WNK1 ADD1 ESF1 CRACD SETD2 ALMS1 AHNAK TPX2 FAM169A EIF5B EIF4G3 SNRNP200 TP53BP2 SON AHNAK2 | 3.73e-14 | 934 | 189 | 29 | 33916271 |
| Pubmed | ZC3H14 FLNA NCOA6 SERBP1 VPS72 PNN MAP4 CDK12 RPS3 NASP CHD8 ADD1 ESF1 DMAP1 SETD2 ALMS1 AHNAK TPX2 PATJ SNRNP200 TP53BP2 RGPD5 | 3.97e-13 | 549 | 189 | 22 | 38280479 | |
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.07e-11 | 11 | 189 | 6 | 35771867 | |
| Pubmed | 1.99e-11 | 22 | 189 | 7 | 27717094 | ||
| Pubmed | RPL21 RGPD4 PRPSAP2 FLNA FLNB RANBP2 SERBP1 NYAP2 ANK2 RGPD8 MAP1A MAP2 MAP4 UFC1 PCLO COPB2 RGPD1 AAK1 NCAM1 BIRC6 TENM2 UBE2N ELFN1 RPTOR RGPD3 FAM169A EIF4G3 SDHA | 2.74e-11 | 1139 | 189 | 28 | 36417873 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | RGPD4 RANBP2 RGPD8 LEO1 MAP1A MAP2 SEPTIN4 PCLO ITSN1 RGPD1 NCAM1 ADD1 PTPRZ1 RGPD3 | 4.08e-11 | 231 | 189 | 14 | 16452087 |
| Pubmed | FLNA FLNB NCOA6 SERBP1 RGPD8 PNN RPS3 FAT3 LEPR FAT2 AHNAK TPX2 SNRNP200 SDHA | 4.84e-11 | 234 | 189 | 14 | 36243803 | |
| Pubmed | RPL21 RGPD4 FLNA FLNB RANBP2 ANK2 RGPD8 LEO1 PNN PPRC1 SPEF2 PCLO ITSN1 RGPD1 CHD4 XPC PALB2 PRX ESF1 TRIM16 YBX2 DGAT2 AHNAK RGPD3 FAM169A EIF5B PPIP5K2 EIF4G3 ATP2B1 PLXNA2 RGPD5 | 6.11e-11 | 1442 | 189 | 31 | 35575683 | |
| Pubmed | RPL21 ZC3H14 NES FLNA FLNB RANBP2 SERBP1 PNN MAP4 COPB2 INTS1 CHD8 CHD4 BIRC6 ESF1 AHNAK EIF5B EIF4G3 SNRNP200 SDHA SON | 8.46e-11 | 653 | 189 | 21 | 22586326 | |
| Pubmed | 9.36e-11 | 7 | 189 | 5 | 9037092 | ||
| Pubmed | 9.36e-11 | 7 | 189 | 5 | 21205196 | ||
| Pubmed | 9.36e-11 | 7 | 189 | 5 | 24403063 | ||
| Pubmed | 9.36e-11 | 7 | 189 | 5 | 23536549 | ||
| Pubmed | 9.36e-11 | 7 | 189 | 5 | 12191015 | ||
| Pubmed | 9.36e-11 | 7 | 189 | 5 | 22821000 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 9.36e-11 | 7 | 189 | 5 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 9.36e-11 | 7 | 189 | 5 | 11353387 | |
| Pubmed | 9.36e-11 | 7 | 189 | 5 | 30944974 | ||
| Pubmed | 9.36e-11 | 7 | 189 | 5 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 9.36e-11 | 7 | 189 | 5 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 9.36e-11 | 7 | 189 | 5 | 17372272 | |
| Pubmed | 9.36e-11 | 7 | 189 | 5 | 38657106 | ||
| Pubmed | 9.36e-11 | 7 | 189 | 5 | 18949001 | ||
| Pubmed | 9.36e-11 | 7 | 189 | 5 | 25187515 | ||
| Pubmed | 9.36e-11 | 7 | 189 | 5 | 8603673 | ||
| Pubmed | 9.36e-11 | 7 | 189 | 5 | 26632511 | ||
| Pubmed | 9.36e-11 | 7 | 189 | 5 | 23818861 | ||
| Pubmed | 9.36e-11 | 7 | 189 | 5 | 20682751 | ||
| Pubmed | RGPD4 ZC3H14 FLNA FLNB RGPD8 MAP4 RGPD1 NASP RPTOR AHNAK RGPD3 SNRNP200 RGPD5 | 2.13e-10 | 215 | 189 | 13 | 35973513 | |
| Pubmed | RPL21 NES FLNA FLNB SERBP1 CTTNBP2 ANK2 MAP1A MAP2 SEPTIN4 MAP4 RPS3 PCLO ITSN1 COPB2 AAK1 NCAM1 ADD1 CRACD PNPLA6 PTPRZ1 RPTOR VCAN MIOS TMOD1 EIF4G3 ATP2B1 SNRNP200 SDHA TP53BP2 | 2.36e-10 | 1431 | 189 | 30 | 37142655 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 2.48e-10 | 8 | 189 | 5 | 21670213 | |
| Pubmed | 2.48e-10 | 8 | 189 | 5 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 2.48e-10 | 8 | 189 | 5 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 2.48e-10 | 8 | 189 | 5 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 2.48e-10 | 8 | 189 | 5 | 28745977 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | DIP2B NES FLNA FLNB MAP2 MAP4 CDK12 RPS3 PCLO INTS1 AAK1 CRACD UBE2N AHNAK VCAN EIF5B PPIP5K2 EIF4G3 | 3.19e-10 | 498 | 189 | 18 | 36634849 |
| Pubmed | FLNA FLNB RANBP2 SERBP1 LEO1 PNN MAP4 CDK12 AAK1 NASP CHD8 WNK1 DMAP1 RPTOR TPX2 EIF5B EIF4G3 SON | 3.74e-10 | 503 | 189 | 18 | 16964243 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | LRRC8E ZXDC FLNA NCOA6 CRYBG2 RHBDF1 PPRC1 CDK12 INTS1 CHD8 WNK1 PLXNB2 BIRC6 DENND1A THAP11 PNPLA6 NFATC1 ZNRF3 ADAMTS7 RPTOR AHNAK MLLT6 WDFY3 ANKRD33B SDHA AHNAK2 | 3.83e-10 | 1105 | 189 | 26 | 35748872 |
| Pubmed | 5.56e-10 | 9 | 189 | 5 | 28100513 | ||
| Pubmed | 5.56e-10 | 9 | 189 | 5 | 17887960 | ||
| Pubmed | 5.56e-10 | 9 | 189 | 5 | 9733766 | ||
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 5.56e-10 | 9 | 189 | 5 | 18394993 | |
| Pubmed | 5.56e-10 | 9 | 189 | 5 | 11553612 | ||
| Pubmed | 5.56e-10 | 9 | 189 | 5 | 10601307 | ||
| Pubmed | 5.56e-10 | 9 | 189 | 5 | 28877029 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 1.11e-09 | 10 | 189 | 5 | 16332688 | |
| Pubmed | 1.11e-09 | 10 | 189 | 5 | 27160050 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 1.11e-09 | 10 | 189 | 5 | 8857542 | |
| Pubmed | 1.11e-09 | 10 | 189 | 5 | 21859863 | ||
| Pubmed | RGPD4 TET2 FLNA FLNB RANBP2 RGPD8 RGPD1 CHD8 CHD4 BIRC6 PALB2 PRDM2 ALMS1 AHNAK RGPD3 TP53BP2 | 1.42e-09 | 418 | 189 | 16 | 34709266 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | NES FLNA FLNB RANBP2 MAP4 SYNM NASP AHNAK TPX2 EIF5B SNRNP200 NBR1 AHNAK2 | 1.80e-09 | 256 | 189 | 13 | 33397691 |
| Pubmed | 2.02e-09 | 11 | 189 | 5 | 17069463 | ||
| Pubmed | 2.02e-09 | 11 | 189 | 5 | 34110283 | ||
| Pubmed | ZC3H14 RANBP2 SERBP1 RHBDF1 VPS72 MAP4 CDK12 PDZK1 INTS1 AAK1 CHD8 XPC DENND1A ESF1 DMAP1 CRACD HABP4 SETD2 PNPLA6 RGPD3 INTS15 TPX2 MIOS EIF5B POLR1B PATJ EIF4G3 SDHA SON | 2.93e-09 | 1497 | 189 | 29 | 31527615 | |
| Pubmed | RGPD4 DIP2B NES RANBP2 NYAP2 CTTNBP2 ANK2 RGPD8 ZNF618 ITSN1 RGPD1 AAK1 NCAM1 CHD8 CHD4 TENM2 ADD1 UBE2N RPTOR RGPD3 MIOS WDFY3 TP53BP2 | 3.25e-09 | 963 | 189 | 23 | 28671696 | |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 5.58e-09 | 13 | 189 | 5 | 31427429 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DIP2B NES RANBP2 MAP1A PNN MAP2 CDK12 RPS3 ZNF618 COPB2 INTS1 CHD9 CHD4 XPC DMAP1 THAP11 SETD2 VCAN MIOS EIF5B PPIP5K2 SNRNP200 TNXB SON | 6.04e-09 | 1082 | 189 | 24 | 38697112 |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 8.26e-09 | 146 | 189 | 10 | 23892456 | |
| Pubmed | 1.29e-08 | 15 | 189 | 5 | 14697343 | ||
| Pubmed | DOCK2 HDAC9 CTTNBP2 SYNM ZNF618 CLSTN1 WNK1 BIRC6 PRX SETD2 FAT2 ALMS1 FAM169A EIF5B ZNF160 SNRNP200 | 1.46e-08 | 493 | 189 | 16 | 15368895 | |
| Pubmed | 2.42e-08 | 86 | 189 | 8 | 37253089 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPL21 NES FLNA FLNB RANBP2 PNN MAP4 RPS3 COPB2 AAK1 CHD8 CHD4 XPC BIRC6 ESF1 PNPLA6 RPTOR AHNAK EIF5B POLR1B WDFY3 ATP2B1 SNRNP200 TP53BP2 SON AHNAK2 | 2.47e-08 | 1353 | 189 | 26 | 29467282 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | DIP2B FLNA FLNB RANBP2 MAP4 RPS3 COPB2 CHD8 CHD4 AHNAK TPX2 SNRNP200 AHNAK2 | 3.97e-08 | 332 | 189 | 13 | 32786267 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 DIP2B NES NCOA6 MAP2 MAP4 AAK1 WNK1 DENND1A MTMR4 ALMS1 ARHGEF10 RPTOR AHNAK PPIP5K2 PATJ EIF4G3 ATP2B1 TP53BP2 AHNAK2 | 5.81e-08 | 861 | 189 | 20 | 36931259 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZC3H14 FLNA NCOA6 RANBP2 SERBP1 VPS72 PNN MAP4 CDK12 RPS3 CHD8 CHD4 ESF1 YBX2 SETD2 AHNAK TPX2 EIF5B MLLT6 SNRNP200 SON | 6.57e-08 | 954 | 189 | 21 | 36373674 |
| Pubmed | ANK2 MAP1A RASGRF1 MAP2 MAP4 RPS3 PCLO ITSN1 AAK1 NCAM1 ADD1 RPTOR EIF4G3 | 6.64e-08 | 347 | 189 | 13 | 17114649 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | FLNA FLNB ERCC1 CTTNBP2 RPS3 CLSTN1 WNK1 CRACD AHNAK VCAN SNRNP200 | 7.56e-08 | 235 | 189 | 11 | 30258100 |
| Pubmed | RPL21 ZC3H14 FLNA NCOA6 RANBP2 SERBP1 PNN MAP4 RPS3 COPB2 CHD9 CHD4 ADD1 ESF1 ADH5 UBE2N WDR87 EIF5B MLLT6 INAVA PATJ CDH3 SDHA TP53BP2 | 8.73e-08 | 1247 | 189 | 24 | 27684187 | |
| Pubmed | ZC3H14 FLNA MAP4 RPS3 CHD4 DTX3L WNK1 AHNAK TPX2 LTBP1 SDHA AHNAK2 | 9.90e-08 | 298 | 189 | 12 | 30737378 | |
| Pubmed | NES RGPD8 CDK12 ITSN1 WNK1 BIRC6 ADD1 SETD2 MTMR4 ALMS1 ARHGEF10 TPX2 MIOS POLR1B PPIP5K2 PATJ NBR1 IQCG | 1.23e-07 | 733 | 189 | 18 | 34672954 | |
| Pubmed | RPL21 FLNA FLNB SERBP1 LEO1 CDK12 NASP CHD4 ADD1 ESF1 DMAP1 CRACD TPX2 SNRNP200 SON | 1.35e-07 | 506 | 189 | 15 | 30890647 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | RGPD4 RANBP2 RGPD8 MAP4 COPB2 RGPD1 AAK1 CHD8 CHD4 ADD1 DMAP1 RGPD3 EIF4G3 | 1.39e-07 | 370 | 189 | 13 | 22922362 |
| Pubmed | 1.58e-07 | 3 | 189 | 3 | 21940993 | ||
| Pubmed | 1.73e-07 | 10 | 189 | 4 | 9184108 | ||
| Pubmed | CHL1 ICAM1 NCAM1 LEPR FREM2 FAT2 CSF1R PTPRJ PTPRZ1 ACAN TNXB | 1.86e-07 | 257 | 189 | 11 | 16335952 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RPL21 ZC3H14 SERBP1 PNN MAP4 CDK12 COPB2 CHD4 BIRC6 ESF1 THAP11 TPX2 MIOS TMOD1 POLR1B EIF4G3 SNRNP200 SON | 2.05e-07 | 759 | 189 | 18 | 35915203 |
| Pubmed | FLNA FLNB ITSN1 E2F3 CHD8 CHD4 CLSTN1 ARHGEF10 AHNAK TP53BP2 SON AHNAK2 | 3.16e-07 | 332 | 189 | 12 | 37433992 | |
| Pubmed | RPL21 FLNB RANBP2 SERBP1 ANK2 MAP4 RPS3 COPB2 AAK1 ADD1 AHNAK EIF5B PATJ EIF4G3 ATP2B1 SNRNP200 SDHA | 3.82e-07 | 708 | 189 | 17 | 39231216 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | RPL21 ZC3H14 FLNA FLNB RANBP2 PNN RPS3 CHD4 AHNAK EIF5B NKTR SNRNP200 SDHA SON | 4.04e-07 | 477 | 189 | 14 | 31300519 |
| Pubmed | NCOA6 CDK12 CHD8 WNK1 BIRC6 ALMS1 ZNRF3 ARHGEF10 WDFY3 SNRNP200 | 4.82e-07 | 225 | 189 | 10 | 12168954 | |
| Pubmed | RPL21 FLNA UBE2NL SERBP1 ANK2 MAP4 CDK12 ICAM1 BCL7B AAK1 CHD4 XPC DENND1A ADD1 THAP11 HABP4 UBE2N AHNAK TPX2 TMOD1 COL14A1 NKTR MX2 SON | 4.86e-07 | 1371 | 189 | 24 | 36244648 | |
| Pubmed | 5.02e-07 | 226 | 189 | 10 | 31452512 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | RPL21 ZC3H14 FLNA RANBP2 SERBP1 MAP1A MAP4 COPB2 AAK1 XPC ADD1 AHNAK EIF5B POLR1B EIF4G3 SON AHNAK2 | 5.20e-07 | 724 | 189 | 17 | 36232890 |
| Pubmed | 6.29e-07 | 4 | 189 | 3 | 17051589 | ||
| Pubmed | 6.29e-07 | 4 | 189 | 3 | 9480752 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOA6 MAP1A ITSN1 WNK1 PRX AEBP1 TPX2 MLLT6 INAVA PATJ EIF4G3 TP53BP2 SON | 7.63e-07 | 430 | 189 | 13 | 35044719 |
| Pubmed | ZC3H14 RANBP2 SERBP1 LEO1 PNN MAP4 CDK12 COPB2 INTS1 CHD9 CHD8 CHD4 ESF1 DMAP1 SETD2 UBE2N AHNAK TPX2 EIF5B SON | 7.71e-07 | 1014 | 189 | 20 | 32416067 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DOCK2 RANBP2 ERCC1 PNN CDK12 PPM1D COPB2 INTS1 CHD8 CHD4 UBE2N AHNAK TPX2 SNRNP200 SNX12 | 7.92e-07 | 582 | 189 | 15 | 20467437 |
| Pubmed | Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells. | 9.01e-07 | 137 | 189 | 8 | 37039823 | |
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | RGPD4 RANBP2 RGPD1 AAK1 IL18R1 ADD1 ALMS1 RGPD3 POLR1B ANKRD36 WDFY3 CNGA3 RGPD5 | 1.04e-06 | 442 | 189 | 13 | 15815621 |
| Pubmed | 1.10e-06 | 15 | 189 | 4 | 24469813 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RPL21 PRPSAP2 NES FLNA FLNB RANBP2 SERBP1 MAP4 CDK12 RPS3 COPB2 NASP CHD4 ADD1 ESF1 ADH5 AHNAK EIF5B PATJ EIF4G3 SNRNP200 | 1.36e-06 | 1149 | 189 | 21 | 35446349 |
| Pubmed | Periaxin is required for hexagonal geometry and membrane organization of mature lens fibers. | 1.46e-06 | 16 | 189 | 4 | 21745462 | |
| Pubmed | 1.46e-06 | 16 | 189 | 4 | 18308476 | ||
| Pubmed | 1.79e-06 | 202 | 189 | 9 | 24639526 | ||
| Pubmed | Dennd1a, a susceptibility gene for polycystic ovary syndrome, is essential for mouse embryogenesis. | 1.90e-06 | 17 | 189 | 4 | 30884041 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | RPL21 RGPD4 NES FLNA FLNB RANBP2 SERBP1 RGPD8 RPS3 ITSN1 CHD4 AHNAK RGPD3 SNRNP200 RGPD5 | 1.95e-06 | 626 | 189 | 15 | 33644029 |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 1.95e-06 | 38 | 189 | 5 | 12791264 | |
| Pubmed | LRRC8E ZC3H14 RANBP2 CRYBG2 INTS1 CHD8 BIRC6 DMAP1 ZSCAN10 ALMS1 UBE2N AHNAK TPX2 | 1.99e-06 | 469 | 189 | 13 | 27634302 | |
| Interaction | NAA40 interactions | RPL21 ZC3H14 FLNA RANBP2 SERBP1 ANK2 MAP1A PNN MAP4 CDK12 MRPL37 AAK1 NASP CHD4 XPC WNK1 ADD1 ESF1 CRACD SETD2 ALMS1 AHNAK TPX2 FAM169A EIF5B TMOD1 EIF4G3 SNRNP200 TP53BP2 SON AHNAK2 | 1.65e-09 | 978 | 186 | 31 | int:NAA40 |
| Interaction | NUP43 interactions | FLNA NCOA6 RANBP2 RGPD8 LEO1 VPS72 PNN MAP4 CDK12 CHD9 CHD8 E2F4 XPC PRDM2 SETD2 FAM169A MLLT6 NKTR EIF4G3 SNRNP200 SON AHNAK2 RGPD5 | 1.76e-08 | 625 | 186 | 23 | int:NUP43 |
| Interaction | RGPD4 interactions | 3.76e-08 | 22 | 186 | 6 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 1.44e-07 | 27 | 186 | 6 | int:RGPD2 | |
| Interaction | SNCA interactions | DIP2B NES FLNA FLNB COL7A1 MAP2 SEPTIN4 MAP4 CDK12 RPS3 PCLO INTS1 AAK1 CRACD UBE2N AHNAK VCAN EIF5B PPIP5K2 PATJ EIF4G3 SNRNP200 NBR1 | 2.06e-07 | 716 | 186 | 23 | int:SNCA |
| Interaction | CIT interactions | RPL21 ZC3H14 NES FLNA FLNB RANBP2 SERBP1 VPS72 PNN RPS3 PCLO BCL7B COPB2 INTS1 CHD8 CHD4 BIRC6 SIRT5 ESF1 MTMR4 ALMS1 ELFN1 AHNAK RGPD3 TPX2 EIF5B POLR1B NKTR PATJ SNRNP200 SDHA SON AHNAK2 | 1.22e-06 | 1450 | 186 | 33 | int:CIT |
| Interaction | DHX8 interactions | ZC3H14 FLNA SERBP1 PNN CDK12 RPS3 CHD4 HABP4 SETD2 POLR1B NKTR SNRNP200 SON | 3.39e-06 | 292 | 186 | 13 | int:DHX8 |
| Interaction | RGPD3 interactions | 4.47e-06 | 47 | 186 | 6 | int:RGPD3 | |
| Interaction | RGPD8 interactions | 5.44e-06 | 74 | 186 | 7 | int:RGPD8 | |
| Interaction | SIRT7 interactions | RPL21 ZC3H14 NES FLNA FLNB RANBP2 SERBP1 PNN MAP4 COPB2 INTS1 CHD8 CHD4 BIRC6 ESF1 AHNAK EIF5B EIF4G3 SNRNP200 SDHA SON | 5.54e-06 | 744 | 186 | 21 | int:SIRT7 |
| Interaction | RGPD1 interactions | 5.73e-06 | 49 | 186 | 6 | int:RGPD1 | |
| Interaction | SYNGAP1 interactions | RPL21 SERBP1 NYAP2 ANK2 MAP1A MAP2 MAP4 COPB2 AAK1 NCAM1 BIRC6 ELFN1 EIF4G3 | 5.84e-06 | 307 | 186 | 13 | int:SYNGAP1 |
| Interaction | SIRT6 interactions | FLNA FLNB RANBP2 ERCC1 RGPD8 VPS72 FAT3 CHD8 CHD4 XPC ESF1 DMAP1 SETD2 TPX2 MIOS POLR1B NKTR SNRNP200 RGPD5 | 6.00e-06 | 628 | 186 | 19 | int:SIRT6 |
| Interaction | TAFA4 interactions | 1.14e-05 | 55 | 186 | 6 | int:TAFA4 | |
| Interaction | KCTD13 interactions | RPL21 NES FLNA FLNB SERBP1 CTTNBP2 ANK2 MAP1A MAP2 SEPTIN4 MAP4 RPS3 PCLO ITSN1 COPB2 AAK1 NCAM1 ADD1 CRACD PNPLA6 PTPRZ1 RPTOR VCAN MIOS TMOD1 EIF4G3 ATP2B1 SNRNP200 SDHA TP53BP2 | 1.20e-05 | 1394 | 186 | 30 | int:KCTD13 |
| Interaction | ZYX interactions | ANK2 SYNM UFC1 ITSN1 AAK1 WNK1 CRACD ALMS1 UBE2N ARHGEF10 NBR1 TP53BP2 AHNAK2 | 1.23e-05 | 329 | 186 | 13 | int:ZYX |
| Interaction | USP14 interactions | RGPD4 FLNA FLNB SERBP1 MAP4 RPS3 COPB2 E2F4 UBE2N AHNAK EIF5B TMOD1 PATJ SNRNP200 AHNAK2 RGPD5 | 1.30e-05 | 489 | 186 | 16 | int:USP14 |
| Interaction | LGALS1 interactions | CHL1 FLNA FAT3 SEZ6L2 PLXNB2 FREM2 PTPRC PTPRJ UBE2N PTPRZ1 VCAN NBR1 PLXNA2 | 1.35e-05 | 332 | 186 | 13 | int:LGALS1 |
| Interaction | PHLPP1 interactions | NES FLNA FLNB RANBP2 MAP4 SYNM NASP AHNAK TPX2 EIF5B SNRNP200 NBR1 AHNAK2 | 1.39e-05 | 333 | 186 | 13 | int:PHLPP1 |
| Interaction | KCNA3 interactions | CHL1 RPL21 FLNB RANBP2 SERBP1 ANK2 MAP4 RPS3 SPEF2 COPB2 AAK1 CHD9 ADD1 PRDM2 RPTOR AHNAK EIF5B PATJ EIF4G3 ATP2B1 SNRNP200 SDHA | 1.86e-05 | 871 | 186 | 22 | int:KCNA3 |
| Interaction | NPIPB6 interactions | 1.94e-05 | 18 | 186 | 4 | int:NPIPB6 | |
| Interaction | ACTB interactions | TET2 DIP2B FLNA FLNB CTTNBP2 LEO1 VPS72 MAP1A MAP2 MAP4 RPS3 ITSN1 ICAM1 CHD4 TPGS2 ADD1 DMAP1 CRACD PNPLA6 ALMS1 TMOD1 POLR1B PATJ NOS3 TP53BP2 | 2.21e-05 | 1083 | 186 | 25 | int:ACTB |
| Interaction | MAD2L1 interactions | ERCC1 SERBP1 VPS72 PNN CHD9 CHD8 E2F4 CHD4 DMAP1 TPX2 PPIP5K2 | 2.34e-05 | 252 | 186 | 11 | int:MAD2L1 |
| Interaction | CLTA interactions | TET2 NES FLNA SERBP1 RPS3 ITSN1 AAK1 WNK1 DENND1A ALMS1 ARHGAP18 NBR1 AHNAK2 | 2.42e-05 | 351 | 186 | 13 | int:CLTA |
| Interaction | YAP1 interactions | RPL21 ZC3H14 FLNA FLNB NCOA6 SERBP1 VPS72 PNN MAP2 MAP4 CDK12 RPS3 COPB2 NASP CHD8 CHD4 ADD1 ESF1 DMAP1 SETD2 AHNAK TPX2 PATJ SNRNP200 TP53BP2 | 2.66e-05 | 1095 | 186 | 25 | int:YAP1 |
| Interaction | RGPD5 interactions | 3.04e-05 | 96 | 186 | 7 | int:RGPD5 | |
| Interaction | SPDL1 interactions | FLNA FLNB ERCC1 CTTNBP2 RPS3 ITSN1 CLSTN1 WNK1 CRACD AHNAK VCAN SNRNP200 | 3.81e-05 | 315 | 186 | 12 | int:SPDL1 |
| Interaction | KIF20A interactions | RPL21 RGPD4 NES FLNA FLNB RANBP2 SERBP1 ANK2 RGPD8 PNN RPS3 PCLO COPB2 CHD8 CHD4 ALMS1 ELFN1 AHNAK RGPD3 TPX2 POLR1B SNRNP200 SON AHNAK2 | 3.96e-05 | 1052 | 186 | 24 | int:KIF20A |
| Interaction | H2BC1 interactions | 4.23e-05 | 178 | 186 | 9 | int:H2BC1 | |
| Interaction | DEFA5 interactions | 4.58e-05 | 70 | 186 | 6 | int:DEFA5 | |
| Interaction | C2CD4B interactions | 5.15e-05 | 44 | 186 | 5 | int:C2CD4B | |
| Interaction | CEBPB interactions | RPL21 RGPD4 DOCK2 HDAC9 ZC3H14 FLNA FLNB RANBP2 ERCC1 SERBP1 LEO1 PNN MAP4 RPS3 COPB2 NASP CHD4 XPC DENND1A DMAP1 PM20D2 UBE2N AHNAK TPX2 EIF5B SNRNP200 NBR1 SDHA SON | 5.95e-05 | 1443 | 186 | 29 | int:CEBPB |
| Interaction | H2BC9 interactions | RPL21 SERBP1 VPS72 PNN RPS3 PCLO ICAM1 CHD4 ESF1 AHNAK ANKRD36 WDFY3 CDH3 TP53BP2 | 7.15e-05 | 446 | 186 | 14 | int:H2BC9 |
| Interaction | RPA4 interactions | RPL21 ZC3H14 FLNA RANBP2 SERBP1 MAP4 NASP XPC ESF1 SETD2 AHNAK TPX2 TP53BP2 SON | 8.24e-05 | 452 | 186 | 14 | int:RPA4 |
| Interaction | VASP interactions | DIP2B XIRP1 MAP1A AAK1 ALMS1 AEBP1 UBE2N ARHGEF10 PATJ NBR1 TP53BP2 | 9.45e-05 | 294 | 186 | 11 | int:VASP |
| Interaction | SLU7 interactions | 1.03e-04 | 156 | 186 | 8 | int:SLU7 | |
| Interaction | NXF1 interactions | LRRC8E ZXDC ZC3H14 NES COL7A1 RANBP2 MAP1A SLC39A1 RPS3 ZNF618 MRPL37 RGPD1 CHD8 E2F4 TPGS2 ESF1 TRIM16 PNPLA6 RPTOR AHNAK WDFY3 ANKRD33B SZRD1 SDHA TP53BP2 SON RGPD5 | 1.12e-04 | 1345 | 186 | 27 | int:NXF1 |
| Interaction | DCAF15 interactions | 1.34e-04 | 255 | 186 | 10 | int:DCAF15 | |
| Interaction | MECP2 interactions | DIP2B NES RANBP2 MAP1A PNN MAP2 CDK12 RPS3 ZNF618 COPB2 INTS1 CHD9 CHD4 XPC ESF1 DMAP1 THAP11 SETD2 VCAN MIOS EIF5B NKTR PPIP5K2 SNRNP200 TNXB SON | 1.38e-04 | 1287 | 186 | 26 | int:MECP2 |
| Interaction | FMR1 interactions | DIP2B RANBP2 SERBP1 PNN RPS3 BCL7B IMPACT E2F4 CHD4 HABP4 AHNAK MIOS INAVA WDFY3 ZBTB3 | 1.41e-04 | 536 | 186 | 15 | int:FMR1 |
| Interaction | PIH1D1 interactions | RPL21 FLNA FLNB RANBP2 SERBP1 MAP4 RPS3 COPB2 BIRC6 SIRT5 UBE2N POLR3E RPTOR AHNAK EIF5B POLR1B SNRNP200 SDHA | 1.53e-04 | 731 | 186 | 18 | int:PIH1D1 |
| Interaction | AP2B1 interactions | FLNA SERBP1 ITSN1 RGPD1 AAK1 AP1M2 E2F4 WNK1 DENND1A MTMR4 ALMS1 ARHGAP18 | 1.89e-04 | 373 | 186 | 12 | int:AP2B1 |
| Interaction | PINK1 interactions | RPL21 ZC3H14 NES FLNA FLNB RANBP2 PNN RPS3 CHD4 TRIM16 AHNAK EIF5B NKTR SNRNP200 SDHA SON AHNAK2 | 1.93e-04 | 679 | 186 | 17 | int:PINK1 |
| Interaction | TERF2IP interactions | ZC3H14 NCOA6 LEO1 VPS72 CDK12 BCL7B INTS1 NASP CHD8 E2F4 PRX DMAP1 SETD2 TPX2 WDFY3 | 1.95e-04 | 552 | 186 | 15 | int:TERF2IP |
| Interaction | AP2S1 interactions | 2.07e-04 | 130 | 186 | 7 | int:AP2S1 | |
| Interaction | YWHAG interactions | TET2 FLNA NCOA6 SERBP1 PNN MAP2 CDK12 SH2D3C AAK1 WNK1 DENND1A CRACD MTMR4 ALMS1 RPTOR NKTR PPIP5K2 PATJ EIF4G3 SNRNP200 NBR1 SDHA TP53BP2 SON AHNAK2 | 2.13e-04 | 1248 | 186 | 25 | int:YWHAG |
| Interaction | SHANK3 interactions | NES FLNA CTTNBP2 ZAN ANK2 MAP1A MAP2 MAP4 ITSN1 AAK1 SETD2 IGSF9 EIF4G3 SDHA | 2.17e-04 | 496 | 186 | 14 | int:SHANK3 |
| Interaction | PTGES3 interactions | RPL21 DIP2B RANBP2 SERBP1 LEO1 MCM8 PPM1D SH2D3C AP1M2 NASP RPTOR PPIP5K2 SNRNP200 | 2.20e-04 | 437 | 186 | 13 | int:PTGES3 |
| Interaction | ITGB2 interactions | 2.28e-04 | 132 | 186 | 7 | int:ITGB2 | |
| Interaction | SFN interactions | TET2 HDAC9 NCOA6 SERBP1 MAP1A MAP2 MAP4 RPS3 AAK1 WNK1 DENND1A MTMR4 ALMS1 ARHGEF10 EIF5B TP53BP2 AHNAK2 | 2.41e-04 | 692 | 186 | 17 | int:SFN |
| Interaction | MEX3A interactions | FLNA FLNB ITSN1 E2F3 CHD8 CHD4 CLSTN1 ARHGEF10 AHNAK TP53BP2 SON AHNAK2 | 2.46e-04 | 384 | 186 | 12 | int:MEX3A |
| Interaction | ADAMTS1 interactions | 2.51e-04 | 95 | 186 | 6 | int:ADAMTS1 | |
| Interaction | H2BC6 interactions | 2.68e-04 | 62 | 186 | 5 | int:H2BC6 | |
| Interaction | HECTD1 interactions | RPL21 ZC3H14 SERBP1 PNN MAP4 CDK12 RPS3 COPB2 AP1M2 CHD4 BIRC6 ESF1 THAP11 ARHGEF10 TPX2 MIOS TMOD1 POLR1B EIF4G3 SNRNP200 SON | 3.08e-04 | 984 | 186 | 21 | int:HECTD1 |
| Interaction | DCPS interactions | DOCK2 FLNB RANBP2 SERBP1 PNN RPS3 AP1M2 AHNAK POLR1B BARX1 SNRNP200 SON | 3.11e-04 | 394 | 186 | 12 | int:DCPS |
| Interaction | NDN interactions | RPL21 FLNA RANBP2 SERBP1 RPS3 COPB2 NASP E2F4 CHD4 LEPR AHNAK EIF4G3 SNRNP200 | 3.11e-04 | 453 | 186 | 13 | int:NDN |
| Interaction | CLTB interactions | 3.30e-04 | 185 | 186 | 8 | int:CLTB | |
| Interaction | MCPH1 interactions | 3.50e-04 | 101 | 186 | 6 | int:MCPH1 | |
| Interaction | HDLBP interactions | RPL21 FLNA UBE2NL SERBP1 PNN CDK12 RPS3 CHD4 XPC PLXNB2 DENND1A SIRT5 THAP11 AHNAK TPX2 TMOD1 COL14A1 ARHGAP18 SDHA | 3.67e-04 | 855 | 186 | 19 | int:HDLBP |
| Interaction | SMC5 interactions | ZC3H14 FLNA NCOA6 RANBP2 SERBP1 VPS72 PNN MAP4 CDK12 RPS3 CHD8 CHD4 ESF1 YBX2 SETD2 AHNAK TPX2 EIF5B MLLT6 SNRNP200 SON | 3.81e-04 | 1000 | 186 | 21 | int:SMC5 |
| Interaction | DPPA3 interactions | 3.86e-04 | 67 | 186 | 5 | int:DPPA3 | |
| Interaction | ZBTB44 interactions | 3.86e-04 | 67 | 186 | 5 | int:ZBTB44 | |
| Interaction | CSF3 interactions | 3.97e-04 | 16 | 186 | 3 | int:CSF3 | |
| Interaction | SUMO2 interactions | HDAC9 DIP2B FLNA FLNB RANBP2 MAP4 RPS3 COPB2 CHD8 CHD4 AHNAK TPX2 SNRNP200 TP53BP2 AHNAK2 | 4.01e-04 | 591 | 186 | 15 | int:SUMO2 |
| Interaction | RIT1 interactions | RPL21 RANBP2 RGPD8 VPS72 PPRC1 CDK12 RPS3 UFC1 COPB2 INTS1 CHD4 BIRC6 ESF1 DMAP1 BCL2L12 UBE2N INTS15 TPX2 POLR1B NKTR SNRNP200 SDHA TBCC SON | 4.21e-04 | 1230 | 186 | 24 | int:RIT1 |
| Interaction | HDAC2 interactions | TET2 HDAC9 ZC3H14 FLNA SERBP1 MAP4 RPS3 CHD4 DTX3L WNK1 DMAP1 NFATC1 RPTOR AHNAK TPX2 COL14A1 LTBP1 SDHA AHNAK2 | 4.24e-04 | 865 | 186 | 19 | int:HDAC2 |
| Cytoband | 2q13 | 1.84e-04 | 68 | 189 | 4 | 2q13 | |
| Cytoband | 2q11.2 | 2.30e-04 | 72 | 189 | 4 | 2q11.2 | |
| GeneFamily | Fibronectin type III domain containing | CHL1 COL7A1 NCAM1 PTPRC PTPRJ PTPRZ1 ELFN1 IGSF9 COL14A1 TNXB | 2.95e-07 | 160 | 133 | 10 | 555 |
| GeneFamily | Immunoglobulin like domain containing | 1.30e-05 | 193 | 133 | 9 | 594 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.25e-05 | 115 | 133 | 7 | 769 | |
| GeneFamily | PDZ domain containing | 1.33e-04 | 152 | 133 | 7 | 1220 | |
| GeneFamily | Cadherin related | 2.45e-04 | 17 | 133 | 3 | 24 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.19e-04 | 4 | 133 | 2 | 574 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 4.70e-04 | 21 | 133 | 3 | 813 | |
| GeneFamily | Intermediate filaments Type IV | 7.90e-04 | 6 | 133 | 2 | 611 | |
| GeneFamily | E2F transcription factors | 1.46e-03 | 8 | 133 | 2 | 982 | |
| GeneFamily | INO80 complex |SRCAP complex | 1.87e-03 | 9 | 133 | 2 | 1329 | |
| GeneFamily | Plexins | 1.87e-03 | 9 | 133 | 2 | 683 | |
| GeneFamily | Ubiquitin conjugating enzymes E2 | 3.38e-03 | 41 | 133 | 3 | 102 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | FLNA MAP4 SYNM ITSN1 INTS1 CHD4 XPC CLSTN1 PLXNB2 TRIM16 PNPLA6 ARHGEF10 AHNAK VCAN | 1.06e-08 | 276 | 184 | 14 | M3063 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | DIP2B RANBP2 RGPD8 PNN CDK12 AAK1 PRDM2 HABP4 POLR3E NKTR ATP2B1 SNRNP200 SON RGPD5 | 2.45e-06 | 432 | 184 | 14 | M41149 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 3.27e-06 | 33 | 184 | 5 | MM477 | |
| Coexpression | FEKIR_HEPARG_SIDE_POP_VS_HEPARG_UP | 3.43e-06 | 90 | 184 | 7 | M48360 | |
| Coexpression | SMID_BREAST_CANCER_BASAL_UP | NES FLNA PLAAT1 MAP2 SYNM ICAM1 NCAM1 E2F3 FAT2 PTPRZ1 ACAN TPX2 LTBP1 INAVA BARX1 CDH3 IQCG | 4.71e-06 | 662 | 184 | 17 | M8124 |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 1.25e-05 | 43 | 184 | 5 | MM3857 | |
| Coexpression | GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN | 1.27e-05 | 200 | 184 | 9 | M9765 | |
| Coexpression | SMID_BREAST_CANCER_LUMINAL_B_DN | DOCK2 NES FLNA PLAAT1 ANK2 SYNM ICAM1 LEPR PTPRC PTPRZ1 VCAN COL14A1 LTBP1 INAVA CDH3 | 1.85e-05 | 587 | 184 | 15 | M17572 |
| Coexpression | ZHAN_MULTIPLE_MYELOMA_PR_DN | 2.40e-05 | 49 | 184 | 5 | M10412 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | CHL1 HDAC9 RANBP2 MAP1A RASGRF1 MAP2 SYNM RPS3 PCLO CHD9 XPC ADH5 CRACD HABP4 PTPRJ TMOD1 EIF4G3 TBCC CREB3L2 | 4.04e-05 | 946 | 184 | 19 | M39169 |
| Coexpression | GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_UP | 8.27e-05 | 198 | 184 | 8 | M8131 | |
| Coexpression | GSE22886_NEUTROPHIL_VS_MONOCYTE_DN | 8.57e-05 | 199 | 184 | 8 | M4467 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP | 8.87e-05 | 200 | 184 | 8 | M9831 | |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_UP | 8.87e-05 | 200 | 184 | 8 | M6254 | |
| Coexpression | BUSSLINGER_DUODENAL_MATURE_ENTEROCYTES | 9.51e-05 | 259 | 184 | 9 | M40029 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | DIP2B RANBP2 RGPD8 CDK12 PPM1D BCL7B PRDM2 HABP4 POLR3E FAM169A EIF4G3 ATP2B1 ANKRD33B SON RGPD5 | 9.76e-05 | 680 | 184 | 15 | M41089 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | ZXDC NES RANBP2 SERBP1 ANK2 LEO1 EFCAB6 MAP1A PNN MAP2 SYNM FAT3 PCLO NASP CHD8 CCDC112 HABP4 CSF1R ALMS1 PTPRJ PTPRZ1 TPX2 FAM169A EIF5B TMOD1 MLLT6 BARX1 | 1.37e-07 | 983 | 186 | 27 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.87e-10 | 200 | 188 | 11 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.60e-09 | 187 | 188 | 10 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | CHL1 RASGRF1 MAP2 PCLO ITSN1 NCAM1 VCAN IGSF21 ATP2B1 ANKRD33B | 1.25e-08 | 197 | 188 | 10 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | CHL1 RASGRF1 MAP2 PCLO ITSN1 NCAM1 VCAN IGSF21 ATP2B1 ANKRD33B | 1.25e-08 | 197 | 188 | 10 | d20f29088e9afd8a960d6f680075c380e550f8a7 |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-07 | 188 | 188 | 9 | 1cd5a4d744bd3777246958ea5eb94388a5cbad81 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-07 | 188 | 188 | 9 | c32d023a69b6da79687ff8fa7485e7499db57046 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-07 | 190 | 188 | 9 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-07 | 191 | 188 | 9 | df8cdbc26443e55a203cbafa21b0952a2a55b9bf | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-07 | 191 | 188 | 9 | 8691eba35793e4e90f93d50c2145847ee51289f7 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.47e-07 | 194 | 188 | 9 | 663e7e7fe48157e808b4f1a0ea6ad41944e857a2 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.60e-07 | 196 | 188 | 9 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.67e-07 | 197 | 188 | 9 | d7cef7881abd807a679432766ced609a6efd1067 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.67e-07 | 197 | 188 | 9 | 20a5958512bdb99daeb8f4d244df53e4f048f879 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.82e-07 | 199 | 188 | 9 | 8ff0fdcbe9661b013913731ec8b53d84836ca865 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-07 | 199 | 188 | 9 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 1.82e-07 | 199 | 188 | 9 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.90e-07 | 200 | 188 | 9 | 881ab995c90d75fd987d6e8f1f926a4bfcc4235f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Cortical_neuron|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.90e-07 | 200 | 188 | 9 | c248233b004f8ef0bab3c65ecfe295887966f2ee | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.90e-07 | 200 | 188 | 9 | af99d90070e2933fd2e9512590c6cf3bd6e15539 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.90e-07 | 200 | 188 | 9 | f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-capillary_endothelial_Hpgd-CA4_high|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.10e-07 | 154 | 188 | 8 | 212c340a096a3a9669d1aebd61c045cf1402a868 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.75e-07 | 167 | 188 | 8 | 784776d1fcc098f84d3c2eca58fa56cb9428f434 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.01e-06 | 180 | 188 | 8 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.10e-06 | 182 | 188 | 8 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | Pericytes-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.15e-06 | 183 | 188 | 8 | 4617b18da8d699a44e4c47980197b1e7eb951470 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.15e-06 | 183 | 188 | 8 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.19e-06 | 184 | 188 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-06 | 185 | 188 | 8 | ca69499ba8c39b7ed6717d05685d6f70066a77bd | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 1.24e-06 | 185 | 188 | 8 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | Dendritic_Cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.30e-06 | 186 | 188 | 8 | 1d52912bd17e232cf39b2423a4d93585c164ba34 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 188 | 188 | 8 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.46e-06 | 189 | 188 | 8 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.52e-06 | 190 | 188 | 8 | ad297172a74a80ed5c10f921e15efd1da0fd2d6b | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.52e-06 | 190 | 188 | 8 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-06 | 191 | 188 | 8 | 2f733d510a4862565a817f59829d8387d7ea26d9 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-22|World / Primary Cells by Cluster | 1.71e-06 | 193 | 188 | 8 | 3b927d4b8ecb21a408424ef91a23746c21741f49 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.71e-06 | 193 | 188 | 8 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 193 | 188 | 8 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 193 | 188 | 8 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-06 | 195 | 188 | 8 | cad21edd90bf3e2fefdf5773a59cb1a664a69ddd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-06 | 195 | 188 | 8 | e10b21e4dba4483efc4c82d6e395524246ca14a8 | |
| ToppCell | PBMC-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 1.84e-06 | 195 | 188 | 8 | 674355ca00314bde90ef7f6ddb83afe2d5323130 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.92e-06 | 196 | 188 | 8 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.99e-06 | 197 | 188 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-06 | 197 | 188 | 8 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-06 | 197 | 188 | 8 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.07e-06 | 198 | 188 | 8 | 7063d74d79f53d5c59c853a2575f9d3ef12f19ea | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-06 | 198 | 188 | 8 | c7dbf24caae5c4ef285845d13055de9e07281bb3 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.15e-06 | 199 | 188 | 8 | 974f71b56f66243c78f2f297a1540e0e186df530 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.15e-06 | 199 | 188 | 8 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.15e-06 | 199 | 188 | 8 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 2.15e-06 | 199 | 188 | 8 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 2.15e-06 | 199 | 188 | 8 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.15e-06 | 199 | 188 | 8 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-06 | 200 | 188 | 8 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.23e-06 | 200 | 188 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.23e-06 | 200 | 188 | 8 | 1decf1d2cba5ebfd3e5cd4bcd637db8f193033ce | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-06 | 200 | 188 | 8 | fd72fe6565e2f4885481991492d58c323ab1ad40 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.23e-06 | 200 | 188 | 8 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.23e-06 | 200 | 188 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.23e-06 | 200 | 188 | 8 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-06 | 200 | 188 | 8 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-06 | 200 | 188 | 8 | fc061de0db2e8b5ca47f5e2a1e861018e7f1b582 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital|World / Primary Cells by Cluster | 2.23e-06 | 200 | 188 | 8 | 6bbe8e1f3e91678f1bfb14945365c1578a59a604 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19|World / Primary Cells by Cluster | 2.23e-06 | 200 | 188 | 8 | c831d9e0a7178e3634da45548f91fa9e8dc6557c | |
| ToppCell | COVID-19-Myeloid-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 4.58e-06 | 156 | 188 | 7 | a07a9096799e4ba663841c70035b4b32c1fda4f9 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-06 | 163 | 188 | 7 | 30cd95d4f37bd54c1fde54960cb005db58bdd30c | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-06 | 163 | 188 | 7 | ab934cb986495adfc8dbe5a276577f2a8fb6ee03 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 7.45e-06 | 168 | 188 | 7 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 7.45e-06 | 168 | 188 | 7 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.05e-06 | 170 | 188 | 7 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.05e-06 | 170 | 188 | 7 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | Monocytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 8.05e-06 | 170 | 188 | 7 | 4e93b66b3033e6e4d5f6d2f41974623a53108f5e | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.36e-06 | 171 | 188 | 7 | 09e653973962fb884878089d281f0947f7a285f6 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.36e-06 | 171 | 188 | 7 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.36e-06 | 171 | 188 | 7 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.69e-06 | 172 | 188 | 7 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.02e-06 | 173 | 188 | 7 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.02e-06 | 173 | 188 | 7 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.02e-06 | 173 | 188 | 7 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.73e-06 | 175 | 188 | 7 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-05 | 176 | 188 | 7 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-05 | 176 | 188 | 7 | bfa1633e1b7a8a2f04d37fa07284fe9bc0199f46 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-05 | 176 | 188 | 7 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-05 | 177 | 188 | 7 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-05 | 178 | 188 | 7 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | AT1-AT2_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.17e-05 | 180 | 188 | 7 | 3c7b2033821f9e34e2924bd8655f566edcbcc7d3 | |
| ToppCell | Control-Myeloid-Dendritic_cells|Control / group, cell type (main and fine annotations) | 1.17e-05 | 180 | 188 | 7 | 25ad95c3c30e3b82abe93bd77ba003f5c2241f7c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 181 | 188 | 7 | 35bcdcd2651149692e5b150e887c0f450c81d2d4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 181 | 188 | 7 | 6d1f1ad35778a2a227f966f11f6edd8e89452576 | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.21e-05 | 181 | 188 | 7 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.21e-05 | 181 | 188 | 7 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-05 | 182 | 188 | 7 | 573771130247e869e4e58f22d4a1cb31989635cf | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-immature_B_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.25e-05 | 182 | 188 | 7 | ab78df9de3878a6d67106a40094c893601de8076 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-05 | 182 | 188 | 7 | 6cfaa2b3b3974c13b01c943f4adb70768dcc35e4 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.30e-05 | 183 | 188 | 7 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 184 | 188 | 7 | 6388c47b7f1d8203e3069eba0e74107256dcae51 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 184 | 188 | 7 | 278a7ed764c326450cb70e69ed2175980eaf5fe0 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 184 | 188 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 184 | 188 | 7 | d83ae1dc64aa1b27d3b524c137567418cc0ff8c6 | |
| Drug | DAPH; Down 200; 10uM; MCF7; HG-U133A | ZC3H14 CDK12 NASP PRX ADD1 YBX2 MTMR4 INTS15 EIF5B ATP2B1 TBCC | 7.43e-07 | 197 | 187 | 11 | 624_DN |
| Drug | Zimelidine dihydrochloride monohydrate [61129-30-4]; Down 200; 9.8uM; HL60; HG-U133A | UBE2NL RANBP2 AAK1 IMPACT E2F4 PRDM2 THAP11 PTPRC AHNAK TPX2 | 5.61e-06 | 197 | 187 | 10 | 2012_DN |
| Drug | Minoxidil [38304-91-5]; Down 200; 19.2uM; PC3; HG-U133A | UBE2NL SEZ6L2 PALB2 SETD2 ALMS1 UBE2N EIF5B EIF4G3 ATP2B1 PLXNA2 | 6.41e-06 | 200 | 187 | 10 | 1914_DN |
| Drug | anemonin | 1.07e-05 | 6 | 187 | 3 | CID000010496 | |
| Disease | Malignant neoplasm of breast | FLNA FLNB NCOA6 COL7A1 XIRP1 ANK2 VPS72 PPM1D PDZK1 FRMPD1 DTX3L WNK1 LEPR PALB2 SETD2 PTPRC CSF1R ZBTB3 NOS3 TP53BP2 | 7.70e-06 | 1074 | 177 | 20 | C0006142 |
| Disease | smoking cessation | NYAP2 CTTNBP2 CDK12 NCAM1 BIRC6 TENM2 LEPR ALMS1 ADAMTS7 IGSF21 | 2.90e-05 | 325 | 177 | 10 | EFO_0004319 |
| Disease | venous thromboembolism, fibrinogen measurement | 5.25e-05 | 67 | 177 | 5 | EFO_0004286, EFO_0004623 | |
| Disease | lymphocyte count | DOCK2 TET2 HDAC9 FLNB NYAP2 ZAN SPEF2 ICAM1 E2F3 CLSTN1 PLXNB2 LEPR HABP4 SETD2 PTPRC ALMS1 PTPRJ NFATC1 ZNRF3 AHNAK POLR1B PPIP5K2 | 7.04e-05 | 1464 | 177 | 22 | EFO_0004587 |
| Disease | Prostatic Neoplasms | TET2 SLC39A1 CDK12 ITSN1 PDZK1 ICAM1 PALB2 SETD2 PTPRC TMOD1 PATJ ZNF160 NOS3 | 9.52e-05 | 616 | 177 | 13 | C0033578 |
| Disease | Malignant neoplasm of prostate | TET2 SLC39A1 CDK12 ITSN1 PDZK1 ICAM1 PALB2 SETD2 PTPRC TMOD1 PATJ ZNF160 NOS3 | 9.52e-05 | 616 | 177 | 13 | C0376358 |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 1.07e-04 | 3 | 177 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 1.07e-04 | 3 | 177 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.36e-04 | 17 | 177 | 3 | DOID:0060307 (is_implicated_in) | |
| Disease | cortical thickness | HDAC9 DIP2B FLNB NYAP2 CTTNBP2 VPS72 FAT3 NCAM1 DENND1A TENM2 ENO4 ADAMTS7 VCAN TPX2 IGSF9 ARHGAP18 EIF4G3 PLXNA2 | 1.36e-04 | 1113 | 177 | 18 | EFO_0004840 |
| Disease | monocyte percentage of leukocytes | CRYBG2 NYAP2 SPEF2 SH2D3C CHD9 WNK1 LEPR ADD1 SETD2 PTPRC CSF1R AHNAK TPX2 WDFY3 | 1.42e-04 | 731 | 177 | 14 | EFO_0007989 |
| Disease | cortical surface area measurement | TET2 HDAC9 FLNB NYAP2 CTTNBP2 ZAN LEO1 MAP2 FAT3 RGPD1 NCAM1 CLSTN1 PLXNB2 DENND1A TENM2 ADAMTS7 VCAN IGSF9 TNXB PLXNA2 | 1.76e-04 | 1345 | 177 | 20 | EFO_0010736 |
| Disease | alcohol consumption measurement | NYAP2 CTTNBP2 CDK12 ZNF618 PCLO BCL7B NCAM1 SEZ6L2 BIRC6 DENND1A TENM2 DMAP1 ADH5 ALMS1 PTPRJ RPTOR EIF5B ANKRD36 PLXNA2 | 1.80e-04 | 1242 | 177 | 19 | EFO_0007878 |
| Disease | Xeroderma Pigmentosum | 2.13e-04 | 4 | 177 | 2 | C0043346 | |
| Disease | Disorder of eye | 3.06e-04 | 212 | 177 | 7 | C0015397 | |
| Disease | Ischemic stroke, fibrinogen measurement | 3.36e-04 | 55 | 177 | 4 | EFO_0004623, HP_0002140 | |
| Disease | fibrinogen measurement, coronary artery disease | 3.45e-04 | 154 | 177 | 6 | EFO_0001645, EFO_0004623 | |
| Disease | Malignant Cystosarcoma Phyllodes | 3.54e-04 | 5 | 177 | 2 | C0600066 | |
| Disease | Phyllodes Tumor | 3.54e-04 | 5 | 177 | 2 | C0010701 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 7.37e-04 | 7 | 177 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | upper aerodigestive tract neoplasm | 7.41e-04 | 246 | 177 | 7 | EFO_0004284 | |
| Disease | Benign Neoplasm | 7.56e-04 | 68 | 177 | 4 | C0086692 | |
| Disease | Neoplasms | 7.56e-04 | 68 | 177 | 4 | C0027651 | |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 8.43e-04 | 31 | 177 | 3 | DOID:3328 (biomarker_via_orthology) | |
| Disease | Hypertensive disease | 1.04e-03 | 190 | 177 | 6 | C0020538 | |
| Disease | Malignant Neoplasms | 1.07e-03 | 128 | 177 | 5 | C0006826 | |
| Disease | granulocyte percentage of myeloid white cells | 1.22e-03 | 268 | 177 | 7 | EFO_0007997 | |
| Disease | Xeroderma pigmentosum | 1.25e-03 | 9 | 177 | 2 | cv:C0043346 | |
| Disease | mean platelet volume | TET2 HDAC9 ZAN CDK12 CHD9 LEPR ADH5 HABP4 SETD2 PTPRC PTPRJ NFATC1 LTBP1 ARHGAP18 NOS3 | 1.30e-03 | 1020 | 177 | 15 | EFO_0004584 |
| Disease | Mammary Carcinoma, Human | 1.33e-03 | 525 | 177 | 10 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.33e-03 | 525 | 177 | 10 | C1257931 | |
| Disease | Mammary Neoplasms | 1.37e-03 | 527 | 177 | 10 | C1458155 | |
| Disease | venous thromboembolism, factor VII measurement | 1.53e-03 | 38 | 177 | 3 | EFO_0004286, EFO_0004619 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.54e-03 | 139 | 177 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | Essential hypertension | 1.56e-03 | 10 | 177 | 2 | cv:C0085580 | |
| Disease | Essential hypertension, genetic | 1.56e-03 | 10 | 177 | 2 | cv:CN305331 | |
| Disease | response to carboplatin, response to antineoplastic agent | 1.56e-03 | 10 | 177 | 2 | GO_0097327, GO_0097328 | |
| Disease | HYPERTENSION, ESSENTIAL | 1.56e-03 | 10 | 177 | 2 | 145500 | |
| Disease | Breast Carcinoma | 1.60e-03 | 538 | 177 | 10 | C0678222 | |
| Disease | stomach cancer (is_marker_for) | 1.70e-03 | 142 | 177 | 5 | DOID:10534 (is_marker_for) | |
| Disease | gastrointestinal stromal tumor (is_implicated_in) | 1.90e-03 | 11 | 177 | 2 | DOID:9253 (is_implicated_in) | |
| Disease | obstructive sleep apnea (is_implicated_in) | 1.90e-03 | 11 | 177 | 2 | DOID:0050848 (is_implicated_in) | |
| Disease | neuroimaging measurement | HDAC9 DIP2B CTTNBP2 MAP2 FAT3 RGPD1 PLXNB2 DENND1A ENO4 ZNRF3 VCAN IGSF9 ARHGAP18 PLXNA2 SZRD1 | 2.05e-03 | 1069 | 177 | 15 | EFO_0004346 |
| Disease | lean body mass | 2.14e-03 | 379 | 177 | 8 | EFO_0004995 | |
| Disease | methionine sulfone measurement | 2.27e-03 | 12 | 177 | 2 | EFO_0800072 | |
| Disease | Essential Hypertension | 2.27e-03 | 12 | 177 | 2 | C0085580 | |
| Disease | coffee consumption measurement, tea consumption measurement | 2.35e-03 | 44 | 177 | 3 | EFO_0006781, EFO_0010091 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.35e-03 | 301 | 177 | 7 | DOID:684 (is_marker_for) | |
| Disease | Neurodevelopmental Disorders | 2.41e-03 | 93 | 177 | 4 | C1535926 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 2.50e-03 | 45 | 177 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | Malignant neoplasm of salivary gland | 2.50e-03 | 45 | 177 | 3 | C0220636 | |
| Disease | white matter microstructure measurement | 2.55e-03 | 390 | 177 | 8 | EFO_0005674 | |
| Disease | cortical surface area measurement, neuroimaging measurement | 2.56e-03 | 227 | 177 | 6 | EFO_0004346, EFO_0010736 | |
| Disease | monocyte count | TET2 FLNB CRYBG2 NYAP2 SPEF2 ICAM1 SH2D3C CLSTN1 WNK1 LEPR SETD2 PTPRC CSF1R VCAN TPX2 POLR1B CREB3L2 | 2.57e-03 | 1320 | 177 | 17 | EFO_0005091 |
| Disease | cerebral amyloid deposition measurement | 2.61e-03 | 95 | 177 | 4 | EFO_0007707 | |
| Disease | hypertension | 2.63e-03 | 307 | 177 | 7 | EFO_0000537 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 2.63e-03 | 157 | 177 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | Schizophrenia | CHL1 HDAC9 CACNA1F PDZK1 ICAM1 NCAM1 CHD4 IL18R1 PTPRZ1 ARHGAP18 TNXB PLXNA2 SDHA | 2.69e-03 | 883 | 177 | 13 | C0036341 |
| Disease | creatinine measurement | TET2 NYAP2 VPS72 CDK12 NASP CHD9 E2F3 PLXNB2 BIRC6 ALMS1 PTPRJ NFATC1 ADAMTS7 IGSF21 | 2.81e-03 | 995 | 177 | 14 | EFO_0004518 |
| Disease | Salivary Gland Neoplasms | 2.83e-03 | 47 | 177 | 3 | C0036095 | |
| Disease | Pneumoconiosis | 3.11e-03 | 14 | 177 | 2 | C0032273 | |
| Disease | Bagassosis | 3.11e-03 | 14 | 177 | 2 | C0004681 | |
| Disease | Adenocarcinoma Of Esophagus | 3.11e-03 | 14 | 177 | 2 | C0279628 | |
| Disease | Adenoid Cystic Carcinoma | 3.14e-03 | 100 | 177 | 4 | C0010606 | |
| Disease | serum albumin measurement | 3.18e-03 | 592 | 177 | 10 | EFO_0004535 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 3.19e-03 | 49 | 177 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | mean arterial pressure | 3.31e-03 | 499 | 177 | 9 | EFO_0006340 | |
| Disease | mean reticulocyte volume | HDAC9 NYAP2 PPRC1 ITSN1 AP1M2 E2F4 CHD4 PTPRC PTPRJ UBE2N TPX2 CDH3 | 3.32e-03 | 799 | 177 | 12 | EFO_0010701 |
| Disease | Hypermetropia | 3.49e-03 | 103 | 177 | 4 | HP_0000540 | |
| Disease | Nephrosis | 3.57e-03 | 15 | 177 | 2 | C0027720 | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 3.57e-03 | 15 | 177 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | neutrophil percentage of leukocytes | TET2 HDAC9 NYAP2 SH2D3C IL18R1 LEPR SETD2 CSF1R NFATC1 ZNRF3 | 3.92e-03 | 610 | 177 | 10 | EFO_0007990 |
| Disease | Chromosome Aberrations | 4.06e-03 | 16 | 177 | 2 | C0008625 | |
| Disease | response to triptolide, cytotoxicity measurement | 4.06e-03 | 16 | 177 | 2 | EFO_0006952, EFO_0007662 | |
| Disease | atherosclerosis (is_implicated_in) | 4.06e-03 | 16 | 177 | 2 | DOID:1936 (is_implicated_in) | |
| Disease | Autosome Abnormalities | 4.06e-03 | 16 | 177 | 2 | C0004403 | |
| Disease | nervousness | 4.06e-03 | 16 | 177 | 2 | NCIT_C74532 | |
| Disease | response to acetylsalicylate | 4.06e-03 | 16 | 177 | 2 | GO_1903492 | |
| Disease | Acute Cerebrovascular Accidents | 4.21e-03 | 54 | 177 | 3 | C0751956 | |
| Disease | Peripheral Nervous System Diseases | 4.21e-03 | 54 | 177 | 3 | C4721453 | |
| Disease | depressive symptom measurement | 4.34e-03 | 426 | 177 | 8 | EFO_0007006 | |
| Disease | coronary artery disease, factor VII measurement | 4.55e-03 | 111 | 177 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | Uremia | 4.59e-03 | 17 | 177 | 2 | C0041948 | |
| Disease | Lipidemias | 4.59e-03 | 17 | 177 | 2 | C1706412 | |
| Disease | 1-Methylhistidine measurement | 4.59e-03 | 17 | 177 | 2 | EFO_0021543 | |
| Disease | pre-eclampsia (biomarker_via_orthology) | 4.59e-03 | 17 | 177 | 2 | DOID:10591 (biomarker_via_orthology) | |
| Disease | factor XI measurement, Ischemic stroke | 4.59e-03 | 17 | 177 | 2 | EFO_0004694, HP_0002140 | |
| Disease | Hyperlipidemia | 4.59e-03 | 17 | 177 | 2 | C0020473 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 4.66e-03 | 56 | 177 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | smoking behavior | 4.66e-03 | 341 | 177 | 7 | EFO_0004318 | |
| Disease | pancreatic cancer (is_implicated_in) | 4.70e-03 | 112 | 177 | 4 | DOID:1793 (is_implicated_in) | |
| Disease | brain aneurysm | 4.85e-03 | 113 | 177 | 4 | EFO_0003870 | |
| Disease | platelet crit | TET2 HDAC9 DIP2B NYAP2 MAP1A AP1M2 LEPR ADH5 HABP4 PTPRC UBE2N POLR1B CDH3 | 5.05e-03 | 952 | 177 | 13 | EFO_0007985 |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 5.14e-03 | 18 | 177 | 2 | EFO_1000649, HP_0000131 | |
| Disease | essential hypertension (is_implicated_in) | 5.14e-03 | 18 | 177 | 2 | DOID:10825 (is_implicated_in) | |
| Disease | schizophrenia, inflammatory bowel disease | 5.14e-03 | 18 | 177 | 2 | EFO_0003767, MONDO_0005090 | |
| Disease | non-alcoholic fatty liver disease (is_implicated_in) | 5.14e-03 | 18 | 177 | 2 | DOID:0080208 (is_implicated_in) | |
| Disease | fibrinogen measurement, factor VII measurement | 5.14e-03 | 58 | 177 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | factor XI measurement, coronary artery disease | 5.16e-03 | 115 | 177 | 4 | EFO_0001645, EFO_0004694 | |
| Disease | myocardial infarction | 5.36e-03 | 350 | 177 | 7 | EFO_0000612 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LAEPVPGIKAEPDES | 16 | P61088 | |
| LAEPVPGIKAEPDES | 16 | Q5JXB2 | |
| VKSEELAPGPIPQVV | 601 | Q68DN1 | |
| TPVPADETPETGLKE | 451 | P55198 | |
| AETTPVAEPTKLVLP | 96 | O15013 | |
| EVDVTGPIKPEPILP | 601 | Q9HCK8 | |
| EESLKEAPSAPVILP | 1176 | Q9NYV4 | |
| VKSGPVSVAEPPLVL | 586 | P0C7U0 | |
| VPVDKVTPSTLPEEV | 136 | Q8NEF3 | |
| GLPSVEKEEVEGRPP | 361 | Q9Y6Q5 | |
| EVTTAKESPEIEPLP | 2306 | Q9NR09 | |
| KKPPLIDREPGEETT | 1231 | P13611 | |
| DVAVESLIPGLEPPV | 826 | Q2M2I8 | |
| AGKPLSIEEIEVAPP | 16 | P11766 | |
| VDKDTPVLSELPEPV | 501 | Q8IUX7 | |
| QELDGKPASPTPVIV | 851 | P35606 | |
| IVPVPTKPTEGQDVT | 321 | Q2WEN9 | |
| IPEEAQKVSPVLGPA | 1211 | Q8TCU4 | |
| PELQGPPSTEKEAIL | 196 | Q9HB09 | |
| PKVGVEVPDVNIEGP | 911 | Q09666 | |
| PKVDIDVPDVNIEGP | 3056 | Q09666 | |
| PDIDITGPKVDINAP | 3376 | Q09666 | |
| PKVDVDVPDVNIEGP | 3966 | Q09666 | |
| PKVDVDVPDVNIEGP | 4686 | Q09666 | |
| SPRSIKDVLPPVEEA | 381 | A6QL64 | |
| PDKNLLEVSGPETVP | 136 | P59074 | |
| VRIPDGVVSVSPKEP | 371 | O94985 | |
| DEPPTLTKEEPVPLE | 156 | Q9BQE9 | |
| PEKEVVSLVPESLSP | 796 | Q13625 | |
| GIEDPVRPEVPDAIK | 681 | P20020 | |
| VPATEPPAAKEEGVL | 1111 | Q9UKP4 | |
| PEGVPESVPETATLL | 76 | A6NCL7 | |
| KTITAEIPDGPPVVA | 231 | Q96B23 | |
| GIPKETDIEIIPEIP | 36 | Q9H095 | |
| EPVVPLPDLVEVSSG | 2311 | P49792 | |
| RTSPPPKEGTVEIEL | 196 | Q5JT25 | |
| PVVPLPDLVEVSSGE | 1336 | Q99666 | |
| PVVPLPDLVEVSSGE | 1336 | O14715 | |
| PLPIVDKGPVELLEE | 36 | Q96N11 | |
| DPLDTPPDSKEGIVV | 476 | Q5T2W1 | |
| EPLPTVKATSPLIEE | 1746 | Q01484 | |
| PLPPSVGVVDKKEET | 81 | Q8NC51 | |
| VVPKEKVVPIPEGSA | 836 | O60840 | |
| KEPPPAVLEADLTEG | 161 | Q8IY17 | |
| GDPRVIKVITEPIPV | 196 | Q12913 | |
| PAKTVKPGRDEPEVL | 521 | Q13478 | |
| KPGRDEPEVLPVLSE | 526 | Q13478 | |
| EPIPETRIEVEIPKV | 351 | Q8WVC0 | |
| SPVGLPPEEEDKLTR | 1776 | P78559 | |
| LGKDVTPPPETEVVL | 516 | P27816 | |
| TPEGVPEQPTFLKVI | 911 | O00533 | |
| KVVPGETIDPIPHQL | 651 | Q9UJA3 | |
| SIKEPSVVPIEVLPT | 106 | Q8N201 | |
| VDEDVLPGKLPETPL | 216 | Q9NU53 | |
| LTEEEVVPSAPPLPV | 576 | Q96FN5 | |
| TEPKEPGESVVIRIP | 2261 | Q5SZK8 | |
| IEEILTEPPGPKGAA | 31 | Q9HBU1 | |
| QGTPEEESPAKVPEL | 266 | Q5JVS0 | |
| GPVELLSIPEDAPEK | 401 | Q9H501 | |
| KFVIPLDEDEVPPGV | 21 | P07992 | |
| IPGSPFRVPVKDVVD | 1406 | O75369 | |
| SSIIESVVPKPEGPV | 2271 | Q9Y6V0 | |
| KDLVSVEPVFSVVPP | 2611 | Q9Y6V0 | |
| PTEEILIPVGEVKPI | 706 | O75051 | |
| PVESVKLTEVPVEPV | 531 | Q9H307 | |
| TKVVFLSPAVPEEPE | 1051 | O15031 | |
| EIKKLSQGSPEPIEP | 1081 | Q6ZWH5 | |
| FVEIPESIPVGSPIL | 1666 | Q9NYQ8 | |
| VIEKTSPPVPVEVAP | 841 | Q14766 | |
| EQPPSVALKVEPVGE | 341 | O95644 | |
| EVIPVPIEVPLTRKD | 426 | Q9P265 | |
| SLEREDKVPGPLEIP | 1506 | P48681 | |
| PEVLEDSPLVPQKGS | 166 | P48357 | |
| VLAEPEKVVTEPPVV | 206 | Q6NSJ5 | |
| VQGVVIPSKDPEPLE | 461 | O15297 | |
| DESPLTPLEVTKLPV | 351 | Q9P242 | |
| AVPSDPILVETPKVD | 1201 | P23471 | |
| VVVEPVGPVGFKPET | 396 | Q9BZE1 | |
| EVEELPPIDHGIPIT | 166 | Q9P2X3 | |
| SEVSEKPGQEAPVLP | 361 | P49321 | |
| EIKVLEETKGPAPDP | 721 | Q9NYA4 | |
| VKPIFEVSPSPLEPE | 401 | P16112 | |
| PAPTEPVAVEQLEKG | 821 | P29474 | |
| VLIPPTAQPEKGVDT | 221 | Q86YC2 | |
| PNVTIKPPGLTDLEV | 1501 | Q14686 | |
| KPPGLTDLEVTPPVV | 1506 | Q14686 | |
| EPVVPLPDLVEVSSG | 1336 | A6NKT7 | |
| PDTESPVPVINLKDG | 2481 | Q3L8U1 | |
| PVIEPSVPELVVKPG | 21 | P07333 | |
| EPLPPVVAGDAVTLK | 31 | Q96ID5 | |
| TSVKPLLQIEAGPPE | 141 | P51878 | |
| IVVKAPPETRLEVPD | 316 | O00716 | |
| EPIKADPTGVLELPK | 336 | Q16254 | |
| EEPISPGSTLPEVKL | 1681 | Q92608 | |
| LVDEKPVPIFLVPTE | 76 | Q8TDB6 | |
| IDGPPTVSPVLVPKD | 571 | Q5THR3 | |
| PGLGPDPKDTIIDVV | 426 | Q9NPF5 | |
| ESPEGISKPVVPADL | 891 | Q8WZ74 | |
| LGIPQVITPEEIVDP | 236 | P21333 | |
| EVDPITTFPLKGLTP | 581 | Q05707 | |
| PGEKIASIPTKEEPQ | 1091 | Q5SYB0 | |
| VEISDSAPPAPLVKE | 1181 | Q6ZU35 | |
| LVKLPTDPSGDEPIF | 1526 | Q15811 | |
| APPLTKEETVQGPIA | 656 | Q8N1P7 | |
| PGVVVAIVKLSPEPI | 391 | Q8TDW7 | |
| EKGISTPRPEIISPV | 206 | Q9HDB8 | |
| VPLVVESSKPPEVDA | 471 | Q9Y6X4 | |
| KEEVPTPTLGSITIP | 686 | Q8TEH3 | |
| TITEKPIAPAEPVEP | 216 | A6NNW6 | |
| GPILQAKPEPVSVDV | 311 | Q6UWL6 | |
| LIPKEKPPITVVGDV | 246 | O60256 | |
| ETGLEPPQKVVLPSD | 451 | Q02388 | |
| PAPNVILTKPEVSEG | 311 | P05362 | |
| IGPPQIEELKVIPET | 66 | Q9NQM4 | |
| KSEVPVGLEPISPLD | 11 | Q9UKV0 | |
| KLERPPETPTVDPTV | 696 | Q14839 | |
| VPPGVRIKEEPVSEE | 491 | Q9NVU0 | |
| KPEGLPPISDVVLDK | 641 | O43432 | |
| GLLLEEEESQVPKPP | 271 | Q3KP66 | |
| VESESLDPPKTIIPE | 711 | Q5VV67 | |
| VPPSKVVEVQEGIPT | 441 | P22223 | |
| ITAISTPLEKEEPPL | 146 | Q70SY1 | |
| TVVGEPITIPKLEHP | 336 | Q96PD7 | |
| TQVPVTEDLPKEPLG | 616 | Q13029 | |
| PVVPLPDLVEVSSGE | 1321 | P0DJD0 | |
| PAETKVPEEIPPEVV | 431 | Q5VT03 | |
| PAETKVPEEIPPEVV | 381 | A1L443 | |
| PAETKVPEEIPPEVV | 366 | Q5VZR2 | |
| VVPVLDKLGPTVFAP | 226 | O95397 | |
| PKVPIVIQDDSLPAG | 41 | Q7Z422 | |
| EPVVPLPDLVEVSSG | 1336 | Q7Z3J3 | |
| IRPPPVEKEEDGTLT | 1451 | Q9C093 | |
| ELERDSKIVVPPLPG | 81 | Q9UMY4 | |
| VVDEEKGELSPVPPN | 1861 | O60522 | |
| PILAKADTLTPPEVD | 286 | O43236 | |
| VPPGTDPETEKLIRE | 441 | O43236 | |
| VPFKVEEVEDVSPGP | 766 | O15061 | |
| KVVKPLDVPAPSLEG | 886 | O15061 | |
| AGVDVTKEPIPVLPT | 391 | P31040 | |
| AEPEPKIPDVAPIVS | 306 | P30414 | |
| EEEEGKAPVPPQVTL | 286 | P0C2Y1 | |
| ETVPLIPEVVELPPS | 806 | Q14596 | |
| EVCVKIEPIPGESPK | 1156 | O60841 | |
| KLDIPSAVPLTAEEP | 21 | Q96CC6 | |
| VEPKDEILPTTPISE | 211 | P23396 | |
| ASIKPVISETPLPVD | 2101 | Q9NT68 | |
| KEEEILPEPGSETPT | 31 | Q6UXD5 | |
| GVEPKDSPPFTVILV | 551 | Q13972 | |
| PPPVKVVVLGTPAEE | 151 | Q8IYS1 | |
| LNVGVDPPDVVKTTP | 66 | Q8N122 | |
| VDVPAPKVEADVSLP | 2011 | Q8IVF2 | |
| PPSTPIKLEEDLVPE | 611 | P35611 | |
| LTLTTIGETPPPVKD | 361 | Q16281 | |
| ETTPLTEPEKGPVEA | 811 | P13591 | |
| DKAPEVPTEGVRLVP | 6 | Q6ZS11 | |
| PIEGTDRVEPKETAP | 246 | Q9Y2T7 | |
| PTTAPEIAVPELDGK | 91 | Q9Y3C8 | |
| TPECVKGVVTDIPPK | 81 | Q9HCG1 | |
| EVKVAEGVPEPNPEL | 276 | Q96SZ4 | |
| TKVEGPEPVPAEASL | 36 | Q5T7W0 | |
| SVPELLAPIKVEPDS | 651 | Q2QGD7 | |
| SEGVVPSPVSLVPEE | 1306 | Q8IZQ1 | |
| TPTPIGDETEPTIIE | 301 | Q9NXC5 | |
| PETKVSEGPVLVLQP | 471 | Q86WA9 | |
| KPLDPVLESVTLEPE | 101 | P28289 | |
| LEPPSDRGTVVEPLK | 461 | Q8NI35 | |
| AVASEPPVPVGLEVK | 16 | Q9NY26 | |
| VPEVRLPEVELPKVS | 486 | Q9BXM0 | |
| EPPIKPRLGELTVTD | 3056 | P22105 | |
| LKDPVEPHGISQVVP | 141 | Q14442 | |
| VRTNGKEPELLEPIP | 141 | P46778 | |
| KDPVVPKEIVPIGDS | 381 | A0A0J9YWL9 | |
| KVDAAPGIPPAVESI | 151 | Q15814 | |
| LRPEAEPELGVKTPE | 1111 | Q9P2J2 | |
| PPLPVEEIIKRSEFV | 91 | Q9HDD0 | |
| LVGEEKLIPPEETPA | 211 | Q8N392 | |
| KLIPPEETPAPETDI | 216 | Q8N392 | |
| PPIIIVPESLEADTK | 241 | Q9BYW2 | |
| TEPSLVVPGIDLPKE | 241 | P11137 | |
| KPPKPADEEIGIIQT | 461 | P11137 | |
| SPGVTEVTIIEKPPA | 31 | Q68CL5 | |
| LERVPIPVKESIEEP | 1041 | O75643 | |
| VGVVKLEQPELDPKP | 121 | Q9ULT6 | |
| VDLGEEPEKPAPSLV | 546 | O95361 | |
| PSAVEVDPIRKPEVP | 141 | Q8N5H7 | |
| VDPIRKPEVPTGDVE | 146 | Q8N5H7 | |
| PLEAEDIPIVPTTSG | 361 | O43314 | |
| SVTVPLVGEPGPKEE | 216 | Q15906 | |
| ESTLVKPEPNGITIP | 1901 | Q9H4A3 | |
| SLLPVKPVEIEIETP | 156 | Q01831 | |
| TILDAVISPPTVPKG | 76 | Q9H9Y6 | |
| EPGTQDASIPVEKLP | 191 | Q9NXA8 | |
| LREVKIEGKPEAPPS | 446 | Q6N021 | |
| PDKTLILDVPPGVEK | 291 | P08575 | |
| SISDEVLEVPKPFIP | 651 | Q6ZQQ6 | |
| PRISPPIKEEETKGD | 406 | Q6PJT7 | |
| APITPTGEDVKPIDL | 176 | Q96EK4 | |
| EAPPKEEVVPGDVRS | 366 | Q702N8 | |
| LVEPPVAKVLEPSET | 291 | P18583 | |
| EKLTIPTEKPTIPIE | 876 | Q9Y493 | |
| PCPTKILEDVVGVPE | 461 | Q9ULW0 | |
| VGPESLRVVEPKDPG | 301 | Q9H5J0 | |
| PEVPDLTIIDLPGIT | 216 | P20592 |